Index

MRCOG Part 1: Comprehensive Embryology Study Guide

Exam Weighting: Moderate-High. Embryology forms the foundation for understanding reproductive physiology, congenital anomalies, placental function, and multiple pregnancy complications. Questions often blend basic science with clinical application.

---

Table of Contents

1. Gametogenesis
2. Fertilisation
3. Early Embryogenesis
4. Formation of Bilaminar Germ Disc
5. Formation of Trilaminar Germ Disc
6. Placental Development
7. Fetal Membranes
8. Embryonic Folding
9. Development of Reproductive System
10. Development of Urinary System
11. Fetal Development Milestones
12. Congenital Abnormalities
13. Twins & Multiple Pregnancy

---

1. Gametogenesis

1.1 Oogenesis

Definition: The process by which primordial germ cells develop into mature oocytes.

Timeline: Begins during fetal life, completes after fertilisation.

Stages of Oogenesis

Stage	Timing	Key Features	Chromosome/Ploidy
Primordial germ cell (PGC)	3rd week of gestation	Migrate from yolk sac wall to genital ridges (~week 6)	2n, 2C (diploid)
Oogonium	Weeks 4–8	Mitotic proliferation; ~7 million by 20 weeks	2n, 2C (diploid)
Primary oocyte	Week 12 gestation to puberty	Enter meiosis I, arrest at prophase I (dictyotene stage); surrounded by primordial follicle	4n, 4C (after S phase)
Secondary oocyte	Ovulation	Completes meiosis I → 2 daughter cells: secondary oocyte (large) + 1st polar body (small); arrests at metaphase II	2n, 2C (haploid, replicated)
Ovum	Fertilisation	Completes meiosis II → ovum + 2nd polar body	1n, 1C (haploid)

Key Numbers

• Peak oogonial number: ~6–7 million at 20 weeks gestation
• At birth: ~1–2 million primary oocytes (massive attrition has already occurred)
• At puberty: ~300,000–400,000
• Ovulated across reproductive life: ~400–500
• Follicular atresia: The default fate; 99.9% of oocytes are lost through apoptosis
• Rate of atresia: Highest in fetal life and during perimenopause

Arrest Points

1. First arrest (prophase I / dictyotene stage): All primary oocytes enter meiosis I in fetal life and arrest at the diplotene stage of prophase I. This state is maintained by oocyte maturation inhibitor (OMI) produced by granulosa cells. The arrest lasts from fetal life until ovulation — up to 50 years. The oocyte remains metabolically active, transcribing mRNA and producing proteins that will be needed after fertilisation. This is why the oocyte is rich in maternal mRNA stores — essential for the first few cleavage divisions before the embryonic genome activates.
2. Second arrest (metaphase II): At ovulation, the secondary oocyte arrests at metaphase II. Completion of meiosis II requires sperm entry (fertilisation) which triggers calcium oscillations within the oocyte. If not fertilised within ~24 hours, the oocyte degenerates by apoptosis. The metaphase II arrest is maintained by maturation-promoting factor (MPF) — a complex of cyclin B1 and CDK1.

Hormonal Control

• FSH: Stimulates follicular growth; promotes granulosa cell proliferation; induces LH receptors on granulosa cells
• LH: Triggers ovulation and resumption of meiosis I (the LH surge activates MPF)
• Oocyte maturation inhibitor (OMI): Maintains meiotic arrest; produced by granulosa cells
• Luteinisation inhibitor: Prevents premature luteinisation before ovulation
• Activin/inhibin: Paracrine regulators of follicular development

Folliculogenesis — The Ovarian Follicle

The oocyte does not develop in isolation — it is supported by follicular cells at every stage:

Follicle Type	Oocyte Stage	Granulosa Cells	Diameter
Primordial follicle	Primary oocyte (arrested)	Single layer of flattened granulosa cells	~30 μm
Primary follicle	Primary oocyte	Single layer of cuboidal granulosa cells	~50 μm
Secondary (pre-antral) follicle	Primary oocyte	Multiple layers (theca interna forms)	~200 μm
Tertiary (antral) follicle	Primary oocyte	Fluid-filled antrum develops; theca externa + interna present	~500 μm–2 cm
Graafian (mature) follicle	Secondary oocyte (MII)	Cumulus oophorus, corona radiata; ready for ovulation	~2–2.5 cm

Theca cells: LH-responsive; produce androstenedione → converted to oestradiol by granulosa cells (FSH-induced aromatase). This two-cell, two-gonadotrophin model is essential for understanding follicular endocrinology.

Clinical Correlations

• POI (Premature Ovarian Insufficiency): Accelerated attrition of primordial follicles before age 40. Causes include genetic (FMR1 premutation, Turner mosaic), autoimmune, and iatrogenic (chemotherapy/radiation).
• Trisomy 21 risk: Increases with maternal age due to prolonged meiotic arrest (the "aged" spindle apparatus → increased non-disjunction). The risk rises exponentially after age 35: ~1:350 at age 35, ~1:100 at age 40, ~1:30 at age 45.
• Chemotherapy/Radiation: Destroy primordial follicles → premature ovarian failure. Alkylating agents (cyclophosphamide) are the most gonadotoxic. Fertility preservation options include oocyte/embryo cryopreservation and ovarian tissue cryopreservation.
• Turner syndrome (45,X): Streak gonads — accelerated oocyte atresia by birth; typically only a few oocytes remain at puberty, leading to primary amenorrhoea and infertility.
• Fragile X (FMR1 premutation): Carriers have elevated risk of POI (FMR1 premutation is found in ~2–5% of women with POI).
• Polycystic Ovary Syndrome (PCOS): Arrest of antral follicle development due to dysregulated steroidogenesis and insulin resistance; not a problem of oogenesis itself but of follicular selection.

Exam Tip: The primary oocyte is formed in fetal life and remains arrested in prophase I (dictyotene) until ovulation — this is the longest cell division arrest in the human body. The secondary oocyte is the cell that is ovulated and enters the fallopian tube.

1.2 Spermatogenesis

Definition: The process by which spermatogonia develop into mature spermatozoa.

Location: Seminiferous tubules of the testis.

Timeline: Begins at puberty; continues throughout life (unlike oogenesis).

Stages of Spermatogenesis

Stage	Process	Ploidy
Spermatogonium (Type A + B)	Mitotic division (self-renewal + expansion)	2n, 2C (diploid)
Primary spermatocyte	Meiosis I (DNA replication → 4C)	4n, 4C
Secondary spermatocyte	Meiosis I completed → 2 cells	2n, 2C (haploid, replicated)
Spermatid	Meiosis II completed → 4 cells	1n, 1C (haploid)
Spermatozoon	Spermiogenesis (morphological transformation)	1n, 1C

Total duration: ~64–74 days (spermatogonium to mature sperm)

Spermiogenesis (Morphological Changes)

1. Golgi phase: Acrosome formation from Golgi apparatus
2. Cap phase: Acrosome spreads over nucleus
3. Acrosomal phase: Elongation of nucleus, flagellum formation
4. Maturation phase: Cytoplasmic shedding as residual body

Structure of Mature Spermatozoon

• Head: Nucleus (haploid DNA) + acrosome (enzyme-filled cap: hyaluronidase, acrosin)
• Midpiece: Mitochondrial sheath (energy production for motility)
• Tail (flagellum): Axoneme (9+2 microtubule arrangement) — responsible for motility

Spermatogenesis vs Oogenesis

Feature	Spermatogenesis	Oogenesis
Timing	Starts at puberty, lifelong	Starts in fetal life, ends at menopause
Duration per cycle	64–74 days	Variable (years to decades)
Product per meiosis	4 functional gametes	1 functional gamete + 2–3 polar bodies
Cytoplasmic division	Equal (symmetrical)	Highly unequal (asymmetrical)
Arrest points	None — continuous	Two arrests (prophase I, metaphase II)
Gamete size	Small (head ~4 μm, length ~50 μm)	Large (~120 μm, ~1000× volume of sperm)
Meiotic completion	Before ejaculation	After fertilisation (meiosis II)
Number produced	~1,000/second (80–300 million/day)	~1/month
Lifetime production	~2 trillion	~400–500
Mitochondrial inheritance	Paternal mitochondria degraded in zygote	Maternal only (all oocyte mitochondria pass to embryo)
Motility	Highly motile (flagellum)	Non-motile
Nucleus	Highly condensed (protamines replace histones)	Diffuse chromatin (histones retained)
Energy source	Glycolysis + oxidative phosphorylation	Pyruvate/oxidative phosphorylation
Genetic recombination	Extensive (chiasmata during meiosis I)	Extensive (longer prophase I = more time for crossing over)
Effect of age	Continuously produced — less age effect on aneuploidy	Stored from fetal life — significant age effect on aneuploidy
Clinical evaluation	Semen analysis (count, motility, morphology)	Ovarian reserve testing (AMH, AFC), IVF outcomes

Key Insight: The cytoplasmic asymmetry of oogenesis ensures that the oocyte retains most of the cytoplasm (organelles, mRNA, nutrients) needed to support early development. The polar bodies are essentially discarded excess chromosomes with minimal cytoplasm.

1.3 Capacitation & Acrosome Reaction

Capacitation

Definition: A series of physiological changes in sperm that occur in the female reproductive tract, enabling them to fertilise an oocyte.

Site: Cervix, uterus, and fallopian tube (primarily the latter).

Duration: ~5–7 hours in humans.

Changes: 1. Removal of decapacitation factors (glycoproteins) from sperm surface 2. Cholesterol efflux from sperm plasma membrane → increased membrane fluidity 3. Increased calcium ion permeability 4. Increased cAMP production 5. Hyperactivation of flagellar motility (vigorous, whip-like) 6. Exposure of surface receptors for zona pellucida binding

Acrosome Reaction

Definition: Exocytosis of the acrosomal contents, triggered by binding to the zona pellucida (specifically ZP3 glycoprotein).

Process: 1. Sperm binds to ZP3 on zona pellucida 2. Calcium influx (mediated by T-type calcium channels) 3. Fusion of outer acrosomal membrane with sperm plasma membrane 4. Release of hydrolytic enzymes: acrosin, hyaluronidase, esterases 5. Penetration through zona pellucida

Exam Tip: Capacitation occurs in the female tract; the acrosome reaction occurs at the zona pellucida. These are DISTINCT processes.

---

2. Fertilisation

2.1 Site

Ampulla of the fallopian tube (the widest, longest portion of the tube). Specifically, fertilisation occurs at the ampullary-isthmic junction.

Why the ampulla? Optimal environment for sperm capacitation, oocyte viability, and early cleavage. Ciliary action and tubal fluid provide nutrition.

2.2 Sperm Transport

• Vagina → Cervix: Sperm deposited in posterior fornix; cervical mucus (mid-cycle, oestrogenic) allows passage
• Cervix → Uterus: Contractions + sperm motility
• Uterus → Tube: Sperm ascend via uterine contractions + flagellar motility
• Time to reach ampulla: ~30 minutes to 2 hours
• Sperm survival in female tract: Up to 5 days (usually 48–72 hours)
• Oocyte viability: ~24 hours after ovulation

2.3 Stages of Fertilisation

Stage 1: Penetration of Corona Radiata

• Capacitated sperm passes through cumulus oophorus cells
• Hyaluronidase from the acrosome and sperm surface helps disperse cells
• Sperm hyperactivation provides mechanical propulsion (vigorous whip-like tail movements)
• The sperm must penetrate ~8–12 cell layers of the corona radiata
• This stage is aided by the rhythmic contractions of the fallopian tube which mix sperm and oocyte

Stage 2: Binding & Penetration of Zona Pellucida

• ZP3 glycoprotein on the zona pellucida acts as the primary sperm receptor
• The zona pellucida has three main glycoproteins: ZP1, ZP2, and ZP3
• Sperm binds specifically to ZP3 via surface receptors (including galactosyltransferase, sp56, and others)
• Binding to ZP3 triggers the acrosome reaction (calcium-dependent exocytosis)
• Acrosin (a trypsin-like serine protease) and other hydrolytic enzymes digest a path through the zona
• The sperm's inner acrosomal membrane is exposed, which contains zona-binding proteins
• Calcium influx is essential — this is mediated by T-type calcium channels and CatSper channels

Stage 3: Fusion of Sperm and Oocyte Membranes

• After penetrating the zona, the sperm reaches the perivitelline space (the gap between the zona and the oolemma)
• The equatorial segment of the sperm head fuses with the oocyte plasma membrane
• This fusion is mediated by IZUMO1 (sperm protein) and JUNO/IZUMO1R (oocyte receptor) — discovered as essential fusion proteins
• Fusion is calcium-dependent and involves other surface proteins (CD9 on the oocyte, fertilin on the sperm)
• The entire sperm enters the oocyte cytoplasm (head, midpiece, and tail — though the tail degenerates quickly)

Stage 4: Cortical & Zona Reaction (Polyspermy Block)

Cortical Reaction: - Upon sperm fusion, the oocyte is activated → calcium oscillations spread across the cytoplasm - These calcium waves are triggered by phospholipase C zeta (PLCζ) delivered by the sperm - Calcium release from the endoplasmic reticulum triggers exocytosis of cortical granules (located just beneath the oolemma) - Cortical granules release their contents (proteases, glycosidases, and peroxidases) into the perivitelline space

Zona Reaction: - Cortical granule enzymes modify the zona pellucida proteins: - ZP2 is cleaved → prevents further sperm binding - ZP3 is inactivated (carbohydrate moieties modified) → no further sperm-ZP3 binding - Zona hardens (cross-linking of zona proteins by ovoperoxidase) - This establishes the permanent block to polyspermy - Timing: The zona reaction takes ~10–20 minutes to become fully effective

Fast Block to Polyspermy: - Within seconds of sperm fusion, the oolemma membrane potential depolarises (from ~−70 mV to ~+10 mV) - This depolarisation prevents additional sperm from fusing with the membrane - This is transient — the zona reaction establishes the permanent block

Exam Tip: There are TWO blocks to polyspermy: (1) Fast block — membrane depolarisation (seconds), and (2) Permanent block — cortical granule exocytosis → zona reaction (minutes). The zona reaction inactivates ZP3, cleaves ZP2, and hardens the zona pellucida.

Stage 5: Completion of Meiosis II

• Sperm entry activates the oocyte (via calcium oscillations → activation of calmodulin-kinase pathway → MPF inactivation)
• The secondary oocyte, arrested at metaphase II, resumes and completes meiosis II
• Result: Mature ovum (haploid, 1n + 1C) + second polar body extruded
• The second polar body is smaller than the first and contains half of the replicated chromosomes
• The two polar bodies eventually degenerate in the perivitelline space

Stage 6: Formation of Male & Female Pronuclei

• Sperm head: The nuclear envelope breaks down → chromatin decondenses (protamines replaced by histones from the oocyte) → new nuclear envelope forms → male pronucleus forms
• Oocyte nucleus: The oocyte completes meiosis II → the remaining haploid set of chromosomes organises into the female pronucleus
• Both pronuclei swell (they are much larger than regular nuclei — ~10× volume)
• DNA replication occurs in both pronuclei (S phase) — each chromosome now consists of two sister chromatids
• The pronuclei migrate toward the centre of the zygote using microtubules (the sperm centriole organises the microtubule array)

Stage 7: Syngamy (Pronuclear Fusion)

• Pronuclear membranes break down
• Maternal and paternal chromosomes intermingle and align on the mitotic spindle
• The two sets of chromosomes (maternal + paternal) align together on the first metaphase spindle
• First mitotic division (cleavage) — the zygote divides into two cells
• The zygote is now truly diploid (2n) with a unique, new genome (a blend of maternal and paternal DNA)

Important: Syngamy does NOT involve fusion of the pronuclei themselves — they break down and mix. The first cleavage division creates the first two blastomeres.

Timeline of Fertilisation Events: - 0 hours: Sperm meets oocyte in ampulla - 0–1 hour: Sperm penetrates corona radiata - 1–2 hours: Sperm binds to and penetrates zona pellucida - 2–4 hours: Sperm-oocyte fusion; cortical reaction; completion of meiosis II - 4–6 hours: Pronuclear formation begins - 6–12 hours: Pronuclear DNA replication - 12–20 hours: Pronuclear migration and syngamy - 24–30 hours: First mitotic cleavage (2-cell stage)

2.4 Chromosomal Recombination

• During meiosis I (in both oogenesis and spermatogenesis)
• Crossing over between homologous chromosomes
• Chiasmata (points of exchange)
• Results in genetic diversity — each gamete is unique

Mnemonics: - CARS: Capacitation, Acrosome reaction, Recognition/binding (ZP3), Syngamy/fusion - OATS: Oocyte → Acrosome → Trigger → Syngamy

2.5 Clinical Correlations

• Fertilisation failure: May be due to abnormal sperm (acrosomal defects, poor motility), tubal blockage, or oocyte abnormalities
• Polyspermy: Rare in humans; prevented by cortical/zona reaction. Occurs in aged oocytes
• ICSI (Intracytoplasmic Sperm Injection): Bypasses acrosome reaction and zona penetration → used for severe male factor infertility
• Tubal factor infertility: Damaged fallopian tubes prevent sperm-oocyte meeting
• Zona hardening → relevance in IVF; may require assisted hatching

---

3. Early Embryogenesis

3.1 Cleavage

Definition: Series of rapid mitotic divisions of the zygote without increase in overall size (the cells become smaller — blastomeres).

Timeline: Days 1–4 post-fertilisation.

Location: Fallopian tube (while the embryo travels toward the uterus).

Stages of Cleavage

Stage	Timing	Cell Number	Description
Zygote	Day 0–1	1	First mitotic division at ~24h
2-cell stage	Day 1–2	2	Each cell is a blastomere
4-cell stage	Day 2	4
8-cell stage	Day 3	8	Compaction begins
Morula	Day 4	16–32	Solid ball of cells (mulberry-shaped)

Key Features: - Divisions occur while the embryo is still within the zona pellucida - No growth in size — the zona pellucida maintains constant diameter - Energy source: Pyruvate (early) → glucose (after compaction) - Maternal-to-zygotic transition (MZT): At ~4–8 cell stage, embryonic genome becomes active; before this, the embryo relies on maternal mRNA deposited in the oocyte

3.2 Compaction

Timing: Day 3 (~8-cell stage).

Process: 1. Blastomeres flatten against each other 2. E-cadherin (cell adhesion molecule) expression increases 3. Tight junctions form between outer cells 4. Gap junctions allow intercellular communication 5. The embryo becomes a cohesive ball

Significance: Establishes inside-outside polarity — cells on the outside become the trophoblast; cells on the inside become the inner cell mass (ICM).

3.3 Blastocyst Formation

Timing: Day 5–6.

Process: 1. Fluid accumulates within the morula → blastocoele (cavity) 2. Two distinct cell populations emerge: - Trophoblast (outer layer): Will form placenta and fetal membranes - Inner cell mass (ICM / embryoblast): Will form the embryo proper 3. Zona pellucida begins to thin

3.4 Hatching

Timing: Day 6–7.

Definition: The blastocyst escapes from the zona pellucida by enzymatic digestion (proteases) and mechanical expansion.

Significance: - Allows direct contact between trophoblast and endometrial epithelium - Required for implantation - The zona pellucida prevents premature implantation and tubal pregnancy

Clinical correlation: Assisted hatching (laser or chemical) may be performed in IVF for embryos with thick zona pellucida, advanced maternal age, or repeated implantation failure.

3.5 Implantation

Timing: Days 6–10 post-fertilisation.

Site: Posterior/superior fundal wall of the uterus (most common).

Phases of Implantation

Phase	Timing	Description
Apposition	Day 6–7	Blastocyst loosely attaches to endometrial epithelium; blastocyst orientates with ICM towards endometrial surface
Adhesion	Day 7–8	Trophoblast binds firmly to endometrial epithelium via integrins, L-selectins, and trophinin molecules
Invasion	Day 8–10	Trophoblast penetrates between endometrial epithelial cells into the stroma; erodes maternal capillaries (sinusoids)

Trophoblast Differentiation During Implantation

• Cytotrophoblast (Langhans cells): Inner layer of mononuclear cells — stem cells for trophoblast
• Syncytiotrophoblast: Outer multinucleated layer formed by fusion of cytotrophoblasts; no cell boundaries visible; produces hCG

The syncytiotrophoblast further differentiates into: - Villous trophoblast: Anchoring and exchange villi - Extravillous trophoblast (EVT): Invades decidua and spiral arteries → remodels maternal vasculature

Decidualisation

Definition: Transformation of endometrial stroma into the decidua in preparation for pregnancy.

Changes: - Stromal cells enlarge → decidual cells (secrete prolactin, IGFBP-1) - Increased vascularity - Leukocyte infiltration (uterine NK cells) - Abundant glycoprotein and lipid deposition

Decidual Regions: - Decidua basalis: Under the embryo (maternal side of placenta) - Decidua capsularis: Over the embryo (covers the conceptus) - Decidua parietalis (vera): Rest of the uterine lining

Implantation Window

Period: Days 20–24 of a 28-day menstrual cycle (LH surge + 6–10 days).

Requirements: - Adequate progesterone levels (from corpus luteum) - Receptive endometrium (pinopodes, integrins) - Appropriate endometrial thickness (≥7 mm) - Normal blastocyst (with functional trophoblast)

3.6 Ectopic Implantation Sites

Site	Frequency	Clinical Notes
Tubal (ampulla)	~70%	Most common ectopic site
Tubal (isthmus)	~12%	Higher risk of rupture
Tubal (fimbrial)	~11%
Tubal (interstitial/cornual)	~2–4%	Highest mortality; bleeds heavily
Ovarian	~3%	Rare
Abdominal	~1%	Very rare; high maternal mortality
Cervical	<1%	Can cause massive haemorrhage
Caesarean scar	Rare	Increasing with CS rates

Risk factors: Tubal damage (PID, previous ectopic, surgery), smoking, IUD, IVF, endometriosis.

Exam Tip: Most ectopics are in the ampulla. Interstitial ectopics present later and are more dangerous due to the distensibility of the cornual myometrium and rich vascular supply.

---

4. Formation of Bilaminar Germ Disc

4.1 The Inner Cell Mass Differentiates

Timing: Day 7–8.

By day 7–8, the inner cell mass (embryoblast) separates into two distinct layers:

1. Epiblast (dorsal layer): Tall columnar cells adjacent to the amniotic cavity
2. Hypoblast (ventral layer): Cuboidal cells adjacent to the blastocoele

This two-layered structure is the bilaminar germ disc.

4.2 Amniotic Cavity

Timing: Day 8.

Formation: - A cavity appears within the epiblast - Amnioblasts (cells derived from epiblast) line the cavity → form the amnion - The amniotic cavity expands as the embryo grows - Function: Protects the embryo, provides buoyancy, allows growth

4.3 Yolk Sac Development

Primary Yolk Sac (Exocoelomic Cavity)

Timing: Day 8–9.

Formation: - Hypoblast cells migrate along the inner surface of the blastocoele → line it to form the exocoelomic membrane (Heuser's membrane) - The cavity enclosed is the primary yolk sac

Secondary (Definitive) Yolk Sac

Timing: Day 12–13.

Formation: - Extraembryonic mesoderm proliferates and splits - A new cavity forms within the extraembryonic mesoderm → chorionic cavity (extraembryonic coelom) - The primary yolk sac shrinks and is replaced by the secondary yolk sac (newly formed from hypoblast) - The secondary yolk sac is much smaller

Functions of Yolk Sac: 1. Primary site of haematopoiesis (weeks 3–6) 2. Source of primordial germ cells (migrate from yolk sac wall to genital ridges) 3. Nutrient and gas exchange (early, before placental circulation established) 4. Forms part of the gut tube after folding 5. Vitelline duct (yolk stalk) connects the yolk sac to the midgut

4.4 Extraembryonic Mesoderm

Timing: Day 9–10.

Origin: Derived from the inner cell mass (epiblast cells that migrate out).

Layers: 1. Extraembryonic somatopleuric mesoderm: Lines the inner surface of the cytotrophoblast and the outer surface of the amnion 2. Extraembryonic splanchnopleuric mesoderm: Surrounds the yolk sac

Split: Fluid accumulates between these two layers to form the chorionic cavity (extraembryonic coelom).

4.5 Chorionic Cavity & Connecting Stalk

Chorionic Cavity (Extraembryonic Coelom): - Forms by day 12 - Surrounds the amnion and yolk sac - Cavity fluid cushions the embryo - The embryo remains connected to the cytotrophoblast by the connecting stalk

Connecting Stalk: - A bridge of extraembryonic mesoderm connecting the embryo to the chorion - Will develop into the umbilical cord - Initially contains the allantois (diverticulum from hindgut) and blood vessels

4.6 Chorion

Definition: The outermost fetal membrane, consisting of: - Syncytiotrophoblast (outer) - Cytotrophoblast (inner) - Extraembryonic mesoderm (inner lining)

Function: Forms the fetal component of the placenta; mediates implantation and maternal-fetal exchange.

Exam Tip: The bilaminar germ disc (epiblast + hypoblast) is the precursor to ALL tissues of the embryo. The epiblast gives rise to ALL three germ layers of the embryo proper through gastrulation — the hypoblast is largely replaced and contributes primarily to extraembryonic structures.

---

5. Formation of Trilaminar Germ Disc

5.1 Gastrulation

Definition: The process by which the bilaminar disc (epiblast + hypoblast) is converted into a trilaminar disc (ectoderm, mesoderm, endoderm).

Timing: Week 3 (day 15–20).

Significance: The single most important event in embryogenesis — establishes the body plan, axes, and germ layers.

Key Structures

Primitive Streak: - Appears at day 15 as a thickened groove on the caudal surface of the epiblast - Defines the craniocaudal axis, left-right axis, and dorsoventral axis - Cells of the epiblast migrate toward the primitive streak and ingress (invaginate) - The primitive streak establishes the midline of the embryo

Primitive Node (Hensen's Node): - The cranial end of the primitive streak - Organizer region analogous to the Spemann organizer in amphibians - Contains the primitive pit (opening) - Governs the organisation of the developing embryo

Cell Movements (Invagination)

Epiblast cells migrate through the primitive streak in a specific spatiotemporal pattern. This is one of the most carefully choreographed events in human development, involving complex cell signalling and cytoskeletal rearrangements.

1. First wave of ingression (days 15–16): Epiblast cells migrate through the primitive streak and displace the hypoblast cells → form definitive endoderm. The hypoblast cells are pushed aside and eventually become confined to the extraembryonic yolk sac.
2. Second wave (days 16–17): Cells migrate between the epiblast and the newly formed endoderm → form intraembryonic mesoderm.
3. Remaining cells in the epiblast that do not migrate through the primitive streak → form ectoderm.

Thus, all three germ layers originate from the epiblast. The hypoblast is displaced and contributes only to extraembryonic structures. This is a fundamental concept: the epiblast is the true "pluripotent" layer of the bilaminar disc.

Mnemonic: "E.M.E." — Epiblast gives rise to Ectoderm (stay behind in epiblast layer), Mesoderm (migrate middle distance), Endoderm (migrate first and furthest).

Molecular Regulation of Gastrulation

• FGF signalling: Required for epiblast cells to adopt a migratory phenotype; FGF4 and FGF8 are key
• Nodal signalling: Essential for primitive streak formation and mesoderm induction; mutations cause gastrulation failure
• Wnt signalling: Promotes cell ingression through the streak; canonical Wnt/β-catenin pathway
• BMP signalling: Provides positional information; gradient of BMP activity patterns the mesoderm
• E-cadherin downregulation: Epiblast cells downregulate E-cadherin to lose epithelial polarity and become migratory
• Snail transcription factors: Repress E-cadherin expression, promoting epithelial-to-mesenchymal transition (EMT)

Epithelial-to-Mesenchymal Transition (EMT): The hallmark of gastrulation. Epiblast cells are initially epithelial (polarised, tight junctions, basement membrane). As they ingress through the primitive streak, they undergo EMT: they become motile, lose polarity, and adopt a mesenchymal phenotype. This process is recapitulated in cancer metastasis — a key exam cross-link.

5.2 Notochord Formation

Process: 1. Cells from the primitive node migrate cranially (headward) through the notochordal process (a hollow tube) 2. The notochordal process grows cranially until it reaches the prechordal plate (future mouth region) 3. The floor of the notochordal process fuses with the underlying endoderm → notochordal plate 4. The notochordal plate folds, detaches from endoderm, and forms the solid notochord

Timing: Days 16–20.

Functions of the Notochord: 1. Induction of neural plate (neural tube formation) 2. Defines the longitudinal body axis 3. Forms the nucleus pulposus of intervertebral discs (the only adult remnant) 4. Patterns the paraxial mesoderm (somite formation)

Prechordal Plate: - A region of thickened endoderm at the cranial end of the notochord - Indicates the site of the future buccopharyngeal membrane - Separates the notochord from the oropharyngeal membrane

5.3 Three Germ Layers: Origins & Derivatives

Ectoderm

Origin: Epiblast cells that do not ingress through the primitive streak.

Subdivisions: 1. Surface ectoderm: Forms epidermis, hair, nails, sweat glands, lens of eye, inner ear, anterior pituitary, enamel of teeth, epithelial linings of nasal and oral cavities 2. Neural ectoderm (neural plate, tube, crest): See below 3. Neural crest cells: A special population that migrates extensively

Derivatives of Neural Crest: - Spinal and cranial nerves (sensory ganglia) - Sympathetic and parasympathetic ganglia - Schwann cells - Adrenal medulla (chromaffin cells) - Melanocytes - Odontoblasts - Membranous bones of the face and skull - Aorticopulmonary septum (heart)

Ectoderm Structure	Specific Derivative
Neural tube	Brain, spinal cord, retina, posterior pituitary
Neural crest	PNS, melanocytes, adrenal medulla, facial skeleton
Surface ectoderm	Epidermis, hair, nails, lens, anterior pituitary

Mesoderm

Origin: Epiblast cells ingressing through the primitive streak.

Subdivisions (from medial to lateral):

1. Paraxial mesoderm (axial): Adjacent to the notochord
2. Forms somites → sclerotome (vertebrae), myotome (muscles), dermatome (dermis)

3. Also forms somitomeres (head and neck region)

4. Intermediate mesoderm: Between paraxial and lateral plate

5. Forms urogenital system (kidneys, gonads, ducts)

6. Lateral plate mesoderm: Most lateral

7. Splits into somatopleuric (body wall) and splanchnopleuric (viscera) layers

8. Forms heart, blood vessels, body wall, limbs, serous membranes

9. Notochordal mesoderm: The notochord itself

Other mesodermal derivatives: - All skeletal muscle (except some head/neck muscles) - Cardiac muscle, smooth muscle - Dermis of the skin - Connective tissues (bone, cartilage, tendon, ligament) - Blood and blood vessels - Lymphatic system - Adrenal cortex - Kidneys and gonads - Spleen - Reproductive tracts

Mesoderm Structure	Derivatives
Paraxial (somites)	Sclerotome → vertebrae/ribs; Myotome → skeletal muscle; Dermatome → dermis
Intermediate	Kidneys, gonads, genital ducts, adrenal cortex
Lateral plate	Heart, blood vessels, body wall, limbs, serous membranes
Notochord	Nucleus pulposus

Endoderm

Origin: Epiblast cells that ingress first through the primitive streak, displacing hypoblast.

Derivatives: - Lining of the gastrointestinal tract (from oropharynx to anal canal) - Lining of the respiratory tract (trachea, bronchi, lungs) - Parenchyma of: liver, gallbladder, pancreas, thyroid, parathyroid - Epithelial lining of: urinary bladder, urethra, auditory tube, tympanic cavity - Thymus

Endoderm Structure	Specific Derivative
Foregut	Pharynx, oesophagus, stomach, liver, gallbladder, pancreas, respiratory tract
Midgut	Small intestine, caecum, ascending colon, proximal 2/3 transverse colon
Hindgut	Distal 1/3 transverse colon, descending colon, sigmoid colon, rectum, upper anal canal

5.4 Neurulation

Definition: The process of neural tube formation from the neural plate (ectoderm).

Timing: Days 17–28 (critical period for neural tube closure).

Key Event: Neural induction — the notochord induces the overlying ectoderm to thicken and form the neural plate.

Stages of Neurulation

1. Neural Plate Formation (Day 17–19):
2. Notochord induces overlying ectoderm → neural plate

3. The plate is thickened, pseudostratified columnar epithelium

4. Neural Folds & Groove (Day 20–22):

5. Neural plate edges elevate → neural folds

6. Central depression → neural groove

7. Neural Tube Closure (Day 22–28):

8. Neural folds meet at the midline and fuse
9. Fusion begins at the cervical region (future junction of brain and spinal cord) and proceeds both cranially and caudally

10. Two openings remain temporarily:

    • Cranial (anterior) neuropore — closes at day 25
    • Caudal (posterior) neuropore — closes at day 28

11. Neural Crest Formation:

12. During neural fold elevation, cells at the crest of the folds detach and migrate
13. Neural crest cells migrate throughout the embryo and differentiate into multiple cell types

Neural Tube Differentiation: - Alar plate (dorsal): Sensory neurons - Basal plate (ventral): Motor neurons - Sulcus limitans: Groove separating alar and basal plates

5.5 Neural Tube Defects (NTDs)

Aetiology: Failure of neural tube closure.

Risk Factors: - Folate deficiency (most important preventable cause) - Genetic predisposition (MTHFR mutations) - Diabetes mellitus - Antiepileptic drugs (valproate, carbamazepine) - Hyperthermia in early pregnancy - Obesity

Types:

Defect	Timing	Description
Anencephaly	Failure of cranial neuropore closure (day 25)	Absence of forebrain and calvarium; lethal
Spina bifida occulta	Mildest form	Vertebral defect without herniation of neural tissue
Spina bifida cystica (meningocele)	Failure of caudal neuropore closure (day 28)	Meninges herniate through defect
Spina bifida cystica (myelomeningocele)	Same	Neural tissue + meninges herniate
Encephalocele	Failure in anterior neural tube closure	Brain tissue herniates through skull defect
Iniencephaly	Severe defect	Neural tube fails to close; extreme retroflexion of head

Prevention: - Periconceptional folic acid: 400 μg daily (general); 5 mg daily (high risk) - Reduces NTD risk by up to 70% - Folic acid fortification of flour is mandatory in many countries

Exam Tip: The critical period for NTD prevention is before neural tube closure (by day 28). Many women do not yet know they are pregnant, which is why supplementation should start pre-conception.

5.6 Somitogenesis

Definition: Formation of somites from paraxial mesoderm.

Timing: Day 20 onwards.

Process: - Paraxial mesoderm segments into paired blocks (somites) - First pair appears at day 20 (cervicothoracic region) - New somites are added caudally at a rate of ~3 pairs per day - By end of week 5: ~42–44 pairs total

Fate of Somites: Each somite differentiates into three components:

1. Sclerotome (ventromedial): Migration around notochord → vertebral bodies, intervertebral discs, ribs
2. Myotome (intermediate): Forms myoblasts → skeletal muscles of back, body wall, and limbs
3. Dermatome (dorsolateral): Forms dermis of the back

Clinical correlation: A single umbilical artery (SUA) can be associated with abnormal somitogenesis and vertebral defects.

Somitomeres: - Transient segmental structures in the head and neck region (before somites form) - 7 somitomeres appear rostral to the first somite - Contribute to the pharyngeal arches and cranial musculature

Exam Tip: The number of somites is a useful indicator of embryonic age (post-fertilisation days). For example: 4–12 somites = day 22–26; ~30 somites = day 30.

---

6. Placental Development

6.1 Trophoblast Differentiation

The trophoblast differentiates into two distinct cell layers very early in implantation:

Layer	Structure	Function
Cytotrophoblast (Langhans cells)	Inner, mononuclear, distinct cell boundaries	Stem cell layer; proliferative; gives rise to syncytiotrophoblast
Syncytiotrophoblast	Outer, multinucleated, no cell boundaries	Invasive; hormone production; gas/nutrient exchange

Syncytiotrophoblast Functions: 1. Hormone production: hCG, hPL (human placental lactogen), progesterone, oestrogen, hCG 2. Invasion: Erodes into endometrium and maternal blood vessels 3. Exchange: Facilitates gas/nutrient/waste transfer between maternal and fetal circulations 4. Immune barrier: Prejects maternal immune system from fetal antigens

6.2 Development of Chorionic Villi

Timing: Weeks 2–8.

Villi develop in three stages:

Stage 1: Primary Chorionic Villi (Week 2)

• Columns of cytotrophoblast extend into the syncytiotrophoblast
• No mesodermal core yet
• These are solid cellular outgrowths

Stage 2: Secondary Chorionic Villi (Week 3)

• Extraembryonic mesoderm grows into the cytotrophoblast columns
• The villus now has a core of mesoderm surrounded by cytotrophoblast, covered by syncytiotrophoblast
• Still no blood vessels

Stage 3: Tertiary Chorionic Villi (End of Week 3)

• Mesodermal core differentiates into blood vessels (fetal capillaries)
• The villus is now complete: syncytiotrophoblast → cytotrophoblast → mesenchyme → fetal vessels
• Placental circulation begins — maternal blood in intervillous space, fetal blood in villous capillaries

Villous Classification

Villus Type	Location	Function
Stem (anchoring) villi	Extend from chorionic plate to decidua basalis	Structural support; anchor placenta
Branch (free) villi	Branch from stem villi; float in intervillous space	Primary site of maternal-fetal exchange
Terminal villi	Smallest branches	Maximise surface area for exchange

6.3 Intervillous Space

Formation: - Erosion of maternal endometrial capillaries (sinusoids) by syncytiotrophoblast - Maternal blood escapes into the spaces between villi → intervillous space - Blood returns to maternal circulation via uterine veins

Maternal blood enters through: - Spiral arteries (decidual branches of uterine arteries) - Remodelled by extravillous trophoblast (EVT) invasion

Maternal blood exits through: - Uterine veins (decidual veins)

Complete intervillous circulation established by: End of week 12.

Important: The intervillous space contains maternal blood; the villi contain fetal blood. The placental barrier separates them. There is NO mixing of fetal and maternal blood under normal circumstances.

6.4 Placental Circulation

Fetal Side

• Deoxygenated fetal blood → umbilical arteries (2) → chorionic arteries → stem villi → villous capillaries → exchange → chorionic veins → umbilical vein (1) → oxygenated blood returns to fetus
• Fetal placental circulation: Low resistance

Maternal Side

• Oxygenated maternal blood → spiral arteries → intervillous space → bathes villi → exchange → deoxygenated blood → uterine veins → maternal circulation
• Maternal placental circulation: High resistance

Blood supply: - Fetus receives ~20–40% of fetal cardiac output - Uterine blood flow increases from ~50 mL/min (non-pregnant) to ~500–800 mL/min at term

6.5 Decidual Plates

• Decidual plate / basal plate: The part of the decidua basalis that forms the maternal surface of the placenta
• Chorionic plate: The fetal surface of the placenta, formed by the chorion
• Between them is the intervillous space

Placental Septa: - Incomplete partitions of decidual tissue extending into the intervillous space - Divide the placenta into cotyledons (15–20 visible lobes on the maternal surface)

6.6 Chorion Frondosum vs Chorion Laeve

Feature	Chorion Frondosum	Chorion Laeve
Location	Over the decidua basalis (embryonic pole)	Over the decidua capsularis (abembryonic pole)
Villi	Abundant, well-developed	Sparse, degenerated by ~week 8
Function	Forms the fetal part of the definitive placenta	Becomes smooth membrane (chorion laeve) fused with amnion
Fate	Becomes the placenta	Fuses with amnion to form the fetal membrane

Why does this happen? The decidua capsularis side has poor blood supply, so villi on that side degenerate.

6.7 Decidua Basalis vs Capsularis vs Parietalis

Decidual Region	Location	Fate
Basalis	Beneath the conceptus (deep)	Forms maternal part of placenta
Capsularis	Over the conceptus (superficial)	Degenerates as pregnancy advances; fuses with parietalis
Parietalis (vera)	Lining the rest of the uterus	Fuses with decidua capsularis by ~week 16; obliterates uterine cavity

Exam Tip: By about 16–20 weeks, the decidua capsularis and parietalis fuse, obliterating the uterine cavity. This is why amniocentesis is performed transabdominallly after 16 weeks.

6.8 Placental Shape Variations

Shape	Description	Clinical Significance
Normal (discoid)	Round/oval, ~15–20 cm diameter, 500 g at term	Normal
Bilobate (two lobes)	Two equal-sized lobes connected by membranes	May cause retained placenta, vasa praevia (if vessels run over os)
Succenturiate (accessory lobe)	Single main lobe + small accessory lobe	High risk of retained placental tissue and postpartum haemorrhage; also vasa praevia risk
Placenta membranacea	Thin, diffuse placenta covering large area	Can cause placenta praevia
Circumvallate	Rolled edges with fibrin ring	Associated with abruption, preterm delivery, antepartum haemorrhage
Battledore (marginal insertion)	Cord inserted at placental margin	Usually benign; slight increase in risk of bleeding
Velamentous cord insertion	Cord inserts into fetal membranes well ahead of placenta	Vasa praevia risk; fetal haemorrhage can be fatal

6.9 Placenta Accreta Spectrum (PAS)

Definition: Abnormal adherence of the placenta to the uterine wall due to deficiency of the decidua basalis and Nitabuch's layer (fibrinoid layer).

Grade	Depth of Invasion	Description
Accreta	Attachment to myometrium (no invasion)	Most common (~75–80%)
Increta	Invasion into myometrium	~15%
Percreta	Invasion through myometrium, into serosa or beyond	~5%; most dangerous

Risk Factors: - Previous caesarean section (strongest risk factor) - Placenta praevia - Advanced maternal age - Multiparity - Previous uterine surgery - Asherman's syndrome

Management: Usually requires caesarean hysterectomy.

Exam Tip: The incidence of PAS is rising due to increasing caesarean section rates. The combination of placenta praevia + previous CS is the strongest predictor.

6.10 Umbilical Cord

Structure: - One umbilical vein: Carries oxygenated blood from placenta to fetus - Two umbilical arteries: Carry deoxygenated blood from fetus to placenta - Wharton's jelly: Mucoid connective tissue surrounding the vessels (prevents compression)

Why two arteries and one vein? This is because the umbilical arteries carry deoxygenated blood (and waste) away from the fetal heart to the placenta — the fetus needs two arteries for the distance and the flow dynamics. The single vein returns oxygenated blood. In the fetus, deoxygenated blood leaves the heart through the internal iliac arteries, via the umbilical arteries.

Vessel	Blood	Direction
Umbilical vein	Oxygenated + nutrient-rich	Placenta → Fetus
Umbilical arteries	Deoxygenated + waste-laden	Fetus → Placenta

Length: ~50–60 cm at term (excessively long or short cords have clinical implications).

Cord Coiling: Normally coiled (left-twist more common). Absent coiling associated with fetal distress, IUGR.

Single Umbilical Artery (SUA): - Occurs in ~1% of pregnancies - Association: Congenital anomalies (especially renal/VACTERL), trisomies (13, 18), IUGR - If isolated → usually normal outcome

Exam Tip: Single umbilical artery should prompt careful fetal anomaly scan, especially looking for renal anomalies.

6.11 Placental Barrier / Membrane

Definition: The tissues separating maternal blood (in intervillous space) from fetal blood (in villous capillaries).

Components (from maternal to fetal side): 1. Syncytiotrophoblast 2. Cytotrophoblast (discontinuous by late pregnancy) 3. Basal lamina 4. Fetal connective tissue (mesenchyme) 5. Endothelium of fetal capillaries

Thickness: Decreases from 50–100 μm (first trimester) to 2–6 μm (term) — the barrier thins significantly to improve exchange.

Transfer Across the Placenta:

Mechanism	Examples
Simple diffusion	O₂, CO₂, water, lipid-soluble substances
Facilitated diffusion	Glucose (via GLUT1)
Active transport	Amino acids, Ca²⁺, Fe, I⁻, vitamins
Pinocytosis	Immunoglobulins (IgG), proteins
Bulk flow	Water flow due to hydrostatic/osmotic gradients

Placental transfer of drugs: Most drugs cross the placenta by simple diffusion. Factors affecting transfer: - Molecular weight (<500 Da crosses easily) - Lipid solubility (highly lipid-soluble drugs cross more readily) - Degree of ionisation (non-ionised forms cross better) - Protein binding (highly protein-bound drugs cross less) - Placental blood flow (flow-limited transfer) - Placental metabolism (the placenta has CYP450 enzymes that can metabolise drugs)

Placental Endocrinology

The placenta is a major endocrine organ — it produces hormones essential for pregnancy maintenance. This is unique: the fetal-placental unit takes over hormone production from the corpus luteum (the "luteal-placental shift").

Hormone	Source	Peak	Function
hCG	Syncytiotrophoblast	8–10 weeks	Maintains corpus luteum; stimulates progesterone production; basis of pregnancy tests
hPL (human placental lactogen)	Syncytiotrophoblast	Rising throughout pregnancy	Metabolic adaptation — insulin resistance, lipolysis, glucose sparing for fetus
Progesterone	Syncytiotrophoblast (corpus luteum first trimester)	Rising throughout pregnancy	Myometrial quiescence; maintenance of decidua; immune modulation
Oestrogen (oestriol, oestradiol, oestrone)	Syncytiotrophoblast (from fetal DHEA-S precursors)	Rising throughout pregnancy	Uterine growth; mammary gland development; increases uteroplacental blood flow
hCG variants	Syncytiotrophoblast	Various	Hyperglycosylated hCG (invasive trophoblast); free β-hCG (screening for aneuploidy)

The Fetal-Placental Unit — Oestrogen Synthesis:

The placenta cannot synthesise oestrogen de novo because it lacks 17α-hydroxylase and 17,20-lyase (CYP17). Instead, it relies on precursors from the fetal adrenal:

1. Fetal adrenal zone produces dehydroepiandrosterone sulphate (DHEA-S)
2. DHEA-S → fetal liver → 16α-hydroxy-DHEA-S
3. Placenta converts 16α-hydroxy-DHEA-S → oestriol (the major oestrogen of pregnancy)
4. DHEA-S can also be converted directly to oestradiol and oestrone

This is why low oestriol levels can indicate fetal adrenal hypoplasia or anencephaly (lack of ACTH drive to the fetal adrenal).

Luteal-Placental Shift: - First 8–10 weeks: Corpus luteum is the main source of progesterone - After ~8–10 weeks: The placenta takes over progesterone production - This is why the corpus luteum is essential in early pregnancy but can be removed after ~10 weeks without causing miscarriage

Placental Immunology

The placenta plays a critical role in maintaining immune tolerance of the semi-allogeneic fetus:

• Trophoblast does not express classical MHC class I (HLA-A, HLA-B) — this prevents T-cell recognition
• HLA-C is expressed on extravillous trophoblast (the only classical MHC I present)
• HLA-G is uniquely expressed on extravillous trophoblast — interacts with uterine NK cells to promote tolerance
• HLA-E is also expressed — another NK cell ligand
• Syncytiotrophoblast lacks MHC molecules entirely — it is immunologically inert
• Decidual NK cells (dNK) are the most abundant immune cell at the maternal-fetal interface; they differ from peripheral NK cells and promote vascular remodelling rather than cytotoxicity
• T-regulatory cells (Tregs) accumulate at the decidua and suppress maternal immune responses against fetal antigens
• Indoleamine 2,3-dioxygenase (IDO) produced by the placenta degrades tryptophan → starves T-cells locally

Exam Tip: The absence of classical MHC-I on trophoblast and the expression of HLA-G are the key immune mechanisms protecting the fetus from maternal rejection. Problems with immune tolerance are implicated in recurrent miscarriage, pre-eclampsia, and IUGR.

Exam Tip: The placental membrane becomes thinner as pregnancy advances, which increases the efficiency of exchange but also increases the risk of transmission of infections and drugs.

---

7. Fetal Membranes

7.1 Amnion

Origin: Epiblast (amnioblasts).

Structure: - Thin, avascular membrane - Inner: Single layer of cuboidal/columnar epithelial cells (amniotic epithelium) - Outer: Avascular connective tissue (extraembryonic somatopleuric mesoderm) - Lines the amniotic cavity

Development: - Forms at day 8 as a cavity within the epiblast - Expands with fetal growth - Eventually fills the entire uterine cavity, fusing with the chorion (chorioamniotic fusion at ~12–14 weeks) - The amnion and chorion are in contact but can be separated by fluid (amniochorionic separation — usually pathological)

Functions: 1. Secretes amniotic fluid 2. Absorbs amniotic fluid 3. Protects the fetus 4. Allows fetal movement 5. Prevents adherence of fetal parts to the uterine wall

7.2 Chorion

Origin: Trophoblast + extraembryonic mesoderm.

Structure: - Outer: Syncytiotrophoblast + cytotrophoblast - Inner: Extraembryonic somatopleuric mesoderm - Thicker and more opaque than amnion

Regions: - Chorion frondosum (villous, placental region) - Chorion laeve (smooth, non-villous region)

Chorioamniotic fusion: The amnion and chorion fuse by ~12–14 weeks. Before this, they are separated by the extraembryonic coelom (chorionic cavity).

7.3 Yolk Sac

Structure: - Primary yolk sac → replaced by secondary (definitive) yolk sac at day 12–13 - Lined by endoderm (hypoblast-derived) externally covered by extraembryonic splanchnopleuric mesoderm - Connected to the midgut via the vitelline (yolk) stalk

Functions: 1. Haematopoiesis (weeks 3–6 — first blood cells) 2. Primordial germ cells origin site 3. Early nutrition (before placental circulation) 4. Forms part of the gut tube (embryonic folding)

Fate: - Regresses as the placenta takes over - The vitelline duct usually obliterates - Remnant: May persist as Meckel's diverticulum (2% of population — a true diverticulum of the ileum, containing all three layers)

7.4 Allantois

Origin: Endodermal diverticulum from the hindgut (caudal yolk sac).

Timing: Appears at day 16.

Structure: - Small, finger-like projection into the connecting stalk - Lined by endoderm; surrounded by extraembryonic mesoderm

Functions: 1. Serves as a conduit for fetal blood vessels (umbilical arteries and vein develop from its mesenchyme) 2. Early role in respiration and excretion (in birds/reptiles; less important in humans) 3. Contributes to urachus (connects bladder to umbilicus)

Fate: - The extraembryonic part degenerates - The intraembryonic part forms the urachus (a fibrous cord connecting the bladder apex to the umbilicus) - In adults, the urachus is the median umbilical ligament

Clinical Correlations: - Patent urachus: Failure of urachal obliteration → urine leaks from umbilicus - Urachal cyst: Sequestration of urachal remnants → may become infected - Allantoic cyst: Remnant of allantois in the umbilical cord

7.5 Amniotic Fluid

Composition: - 98–99% water - Electrolytes (Na⁺, K⁺, Cl⁻, HCO₃⁻) - Proteins (albumin, alpha-fetoprotein) - Carbohydrates (glucose, lactate) - Lipids - Hormones (hPL, prolactin) - Growth factors - Fetal cells (squamous epithelial cells, desquamated) - Vernix caseosa, lanugo hairs - Urea, creatinine (fetal urine)

Volume Changes Across Gestation

Gestation	Volume (mL)	Source
Week 10	~30	Fetal skin diffusion, amnion secretion
Week 16	~200	Fetal urine begins contributing
Week 20	~350
Week 28	~800	Fetal urine primary source
Weeks 34–36	~800–1000 (peak)	Maximum volume
Week 40	~700–800	Declining
Post-term (42+ wks)	~400–500	Decreasing significantly

Sources of Amniotic Fluid: 1. Fetal urine (primary source from second trimester onwards — ~600–800 mL/day at term) 2. Amnion secretions (first trimester) 3. Fetal lung fluid (respiratory tract secretions — ~300–400 mL/day at term) 4. Transudation from fetal skin (first trimester; keratinisation of skin by ~24 weeks stops this)

Removal of Amniotic Fluid: 1. Fetal swallowing (~500 mL/day at term) 2. Intramembranous absorption (across amnion into fetal blood vessels) 3. Transmembranous absorption (across amnion into maternal tissues)

Circulation: The entire volume of amniotic fluid is replaced approximately every 3 hours at term.

Functions of Amniotic Fluid

1. Physical protection: Cushions the fetus from mechanical trauma
2. Thermal regulation: Maintains stable temperature
3. Allows fetal movement: Prevents contractures, enables musculoskeletal development
4. Prevents adherence: Stops fetal parts from adhering to the amnion
5. Lung development: Fetal breathing movements draw amniotic fluid into the lungs → essential for lung growth and surfactant production
6. Intestinal development: Fetal swallowing promotes gut maturation
7. Microbial barrier: Amniotic fluid contains lysozyme and other antibacterial factors
8. Umbilical cord protection: Prevents compression
9. Birth canal: Amniotic sac hydraulically dilates the cervix; fluid lubricates the birth passage

Abnormalities of Amniotic Fluid Volume:

Condition	Volume	Causes
Polyhydramnios	>2000 mL (or AFI >24 cm, or single deepest pocket >8 cm)	Fetal GI obstruction (oesophageal atresia, duodenal atresia), neurological disorders (anencephaly impairing swallowing), twin-to-twin transfusion (recipient), idiopathic, maternal diabetes
Oligohydramnios	<500 mL (or AFI <5 cm, or single deepest pocket <2 cm)	Fetal renal anomalies (renal agenesis — Potter syndrome), preterm PROM, IUGR, post-term pregnancy, placental insufficiency

Exam Tip: The normal amniotic fluid volume peaks at ~34–36 weeks. Polyhydramnios is associated with fetal GI obstruction (can't swallow). Oligohydramnios is associated with fetal renal anomalies (can't pee) — the classic mnemonic is "Pee or Swallow" for amniotic fluid regulation.

---

8. Embryonic Folding

8.1 Overview

Timing: Weeks 4–8 (critical period).

Definition: The flat trilaminar germ disc transforms into a cylindrical embryo through folding in two planes.

Why does folding occur? - The embryo grows rapidly, especially the nervous system - The flat disc must be transformed into a tube-within-a-tube body plan - The yolk sac is incorporated into the body

Folding occurs in two directions: 1. Cephalocaudal (longitudinal) — head-to-tail folding 2. Lateral (transverse) — side-to-side folding

8.2 Cephalocaudal Folding

Due to: - Rapid growth of the neural tube (especially the brain, which enlarges cranially) - Growth of the somites

Cranial Fold (Head Fold): 1. The developing brain grows rapidly in a cranial direction, overhanging the oropharyngeal membrane 2. The septum transversum (mesodermal structure, precursors of the diaphragm and liver) is pulled ventrally 3. The oropharyngeal membrane comes to lie at the ventral surface of the embryo (future mouth) 4. The pericardial cavity moves ventrally, coming to lie anterior to the foregut 5. A portion of the yolk sac is incorporated as the foregut

Caudal Fold (Tail Fold): 1. The terminal part of the neural tube (caudal eminence) grows caudally 2. The cloacal membrane (future anus) moves to the ventral surface 3. The connecting stalk (future umbilical cord) moves ventrally 4. The allantois is partially incorporated into the body 5. A portion of the yolk sac is incorporated as the hindgut

8.3 Lateral Folding

Due to: - Growth of the somites and lateral body walls - Differential growth between the embryo and the yolk sac

Process: 1. The lateral edges of the embryonic disc fold ventrally 2. The somatopleuric mesoderm (ectoderm + mesoderm) forms the body wall 3. The splanchnopleuric mesoderm (endoderm + mesoderm) forms the gut wall 4. The lateral body folds meet in the ventral midline 5. The yolk sac is progressively constricted, remaining connected by the vitelline duct (narrow stalk)

8.4 Results of Folding

Structure	Before Folding	After Folding
Embryo shape	Flat, disc-shaped	Cylindrical, C-shaped
Yolk sac	Open, ventral to disc	Constricted, connected by vitelline duct
Gut tube	Flat sheet of endoderm	Closed tube (foregut, midgut, hindgut)
Oropharyngeal membrane	Cranial edge	Anterior (ventral) — future mouth
Cloacal membrane	Caudal edge	Posterior (ventral) — future anus
Heart & pericardium	Cranial to neural plate	Ventral to foregut
Connecting stalk	Caudal to disc	Ventral (umbilical region)
Amniotic cavity	Dorsal to embryo	Surrounds entire embryo

Critical Concept: After folding, the embryo has an outer ectodermal covering (skin) and an inner endodermal lining (gut), with mesoderm in between.

8.5 Incorporation of Yolk Sac

• The intraembryonic part of the yolk sac is incorporated into the gut tube
• The extraembryonic part remains outside and atrophies
• The vitelline duct (yolk stalk) connects the midgut to the yolk sac
• The vitelline duct normally obliterates by week 10
• The vitelline vessels form part of the portal system

Clinical correlation: Failure of the vitelline duct to obliterate results in Meckel's diverticulum (a true diverticulum containing all three layers of the GI tract wall). Often follows the "rule of 2s" : 2% of population, 2 inches long, 2 feet from the ileocaecal valve, 2 times more common in males, usually presents by age 2.

---

9. Development of Reproductive System

9.1 Indifferent Stage (Gonadal Ridge)

Timing: Weeks 4–6.

Key Point: The early embryo has the potential to develop into either male or female — the gonad remains bipotential until week 7.

Structures Present in the Indifferent Stage

Genital (Gonadal) Ridges: - Thickening of intermediate mesoderm on the medial side of the mesonephros - Appear at week 5 - Primordial germ cells (PGCs) migrate from the yolk sac wall (near the allantois) into the genital ridges by week 6 - PGCs are identifiable by their alkaline phosphatase activity - PGCs migrate via the hindgut mesentery

Two Duct Systems (both present):

1. Mesonephric (Wolffian) Ducts:
2. Originate from the mesonephros (intermediate kidney)
3. Run caudally to open into the urogenital sinus
4. Will differentiate into male internal genitalia (epididymis, vas deferens, seminal vesicles)

5. In females, they regress

6. Paramesonephric (Müllerian) Ducts:

7. Develop lateral to the mesonephric ducts
8. Appear by week 6
9. Cranial end opens into the coelomic cavity (future fimbrial end of the tube)
10. Caudal ends fuse to form the uterovaginal primordium (uterine canal)
11. Will differentiate into female internal genitalia (fallopian tubes, uterus, upper vagina)
12. In males, they regress

9.2 Sex Determination

Chromosomal Sex: Established at fertilisation (XX or XY).

Gonadal (Primary) Sex Determination: The type of gonad that develops (testis or ovary).

Gene	Chromosome	Function
SRY (Sex-determining Region Y)	Yp11.2	Testis-determining factor — initiates testicular development from the indifferent gonad
SOX9	17q24.3	Downstream of SRY; critical for Sertoli cell differentiation
SF1 (NR5A1)	9q33.3	Steroidogenic factor; essential for gonad development in both sexes
DAX1 (NR0B1)	Xp21.3	Ovarian development; when duplicated → XY sex reversal; when deleted in XY → male development but adrenal hypoplasia
WNT4	1p36.12	Ovarian development; suppresses Leydig cell development; important for Müllerian duct maintenance
RSPO1	1p34.3	Female sex determination; promotes WNT signalling

Flow of Sex Determination

XY (Male) Pathway: SRY (Y chromosome) → SOX9 upregulation → Sertoli cell differentiation → testis formation → Leydig cells produce testosterone + Sertoli cells produce MIS/AMH

XX (Female) Pathway: Absence of SRY → DAX1, WNT4, RSPO1 promote ovarian development → no Sertoli or Leydig cells → no MIS → Müllerian ducts persist → no testosterone → Wolffian ducts regress

Exam Tip: The key concept: SRY drives testicular development. In its absence, ovaries develop by default. This is a "male-driven" system of sex determination.

9.3 Male Development

Testis Formation (Week 7)

1. SRY expression in genital ridge at week 6–7
2. Differentiation of Sertoli cells (from coelomic epithelium) — produce Müllerian Inhibiting Substance (MIS/AMH)
3. Differentiation of Leydig cells (from mesenchyme) — produce testosterone from week 8
4. Testicular cords form → become seminiferous tubules
5. Regression of the outer cortex (the ovary would develop from the cortex)

Hormonal Regulation of Male Internal Genitalia

Testosterone (from Leydig cells): - Stimulates Wolffian duct differentiation (epididymis, vas deferens, seminal vesicles) - Paracrine action on the ipsilateral duct (one testis supports one side)

Müllerian Inhibiting Substance / Anti-Müllerian Hormone (from Sertoli cells): - Causes regression of Müllerian ducts (paracrine) - Prevents development of uterus and fallopian tubes

5α-Reductase: - Converts testosterone → dihydrotestosterone (DHT) - DHT is the active hormone for male external genitalia development

Male External Genitalia

Timing: Weeks 8–12.

Under DHT influence: - Genital tubercle → glans penis - Urogenital folds → shaft of penis - Labioscrotal swellings → scrotum - Urogenital sinus → prostatic and membranous urethra

Phallic growth: Under DHT → penile development

Testicular Descent (see separate section below)

9.4 Female Development

Ovary Formation (Week 7–8)

1. Absence of SRY → cortex of indifferent gonad develops into ovary
2. Primary sex cords degenerate; secondary (cortical) sex cords form
3. Primordial germ cells enter the cortex → differentiate into oogonia
4. Oogonia enter meiosis I → become primary oocytes (by week 12)
5. Primary oocytes surrounded by granulosa cells → primordial follicles
6. Medulla regresses; the ovary becomes a cortical structure

Female Internal Genitalia

Without MIS: - Müllerian ducts persist and differentiate

Müllerian Duct Differentiation: 1. Cranial aspect → fallopian tubes (the open end becomes the fimbriae) 2. Caudal aspect fuses → uterus (from fused paramesonephric ducts) 3. Most caudal aspect → upper vagina (the sinovaginal bulbs from the urogenital sinus form the lower vagina) 4. The fused Müllerian ducts are initially separated by a septum → the septum degenerates by week 20

Without Testosterone: - Wolffian ducts regress spontaneously (they require testosterone to persist) - Only remnants remain: the Gartner's duct (mesonephric duct remnant, may form cysts)

Female External Genitalia

Without DHT: - Genital tubercle → clitoris - Urogenital folds → labia minora - Labioscrotal swellings → labia majora - Urogenital sinus → lower vagina and urethra

9.5 External Genitalia Summary

Structure	Male (DHT-dependent)	Female (no DHT)
Genital tubercle	Glans penis	Clitoris
Urogenital folds	Penile shaft	Labia minora
Labioscrotal swellings	Scrotum	Labia majora
Urogenital sinus	Prostatic + membranous urethra	Lower vagina, urethra

Mnemonic: "MALES" — Median (genital tubercle) → glans; ALar (urogenital folds) → shaft; External (labioscrotal) → scrotum.

9.6 Müllerian Anomalies (Overview)

For detailed embryology, classification, clinical features, and management of all Müllerian anomaly classes, see Section 9.12 — Müllerian (Paramesonephric) Duct Anomalies below.

9.7 Testicular Descent

Timing: - First phase (transabdominal): Weeks 8–15 - Second phase (inguinoscrotal): Weeks 26–35 (often completes by birth)

First Phase: Transabdominal Descent (Weeks 8–15)

• Under hormonal control: MIS/AMH (from Sertoli cells) is the primary driver
• The testis moves from the posterior abdominal wall (near the kidney) to the deep inguinal ring
• Gubernaculum: A fibromuscular cord connecting the testis to the scrotal swelling
• The gubernaculum shortens and thickens, guiding the testis downward
• The processus vaginalis (peritoneal evagination) precedes the testis

Second Phase: Inguinoscrotal Descent (Weeks 26–35)

• Under androgen control (testosterone ± DHT)
• The testis traverses the inguinal canal
• The gubernaculum elongates toward the scrotum
• The processus vaginalis invaginates into the scrotum
• The testis passes through the external ring into the scrotum
• The processus vaginalis normally obliterates → becomes the tunica vaginalis testis

Structures in the Spermatic Cord (Male)

• Vas deferens
• Testicular artery
• Pampiniform plexus (veins)
• Genital branch of genitofemoral nerve
• Cremasteric artery
• Processus vaginalis (obliterated)
• Lymphatics

Factors Involved in Descent

Factor	Role
MIS/AMH	Primary driver of transabdominal phase
Testosterone	Drives inguinoscrotal phase
Gubernaculum	Guides the testis; directional guidance
Intra-abdominal pressure	Contributes to passage through inguinal canal
CGRP (calcitonin gene-related peptide)	From genitofemoral nerve; stimulates gubernacular migration
Processus vaginalis	Creates peritoneal pathway for descent

Clinical Correlations

• Cryptorchidism (undescended testis):
• Incidence: 3% of term newborns, 30% of premature infants
• Most descend spontaneously in first 3 months
• Associated with: Prematurity, low birth weight, hormonal abnormalities
• Risks: Impaired spermatogenesis, increased risk of testicular cancer (seminoma), torsion risk

• Management: Orchidopexy by 12–18 months

• Ectopic testis: Testis descends to an abnormal location (superficial inguinal pouch, perineum, femoral canal)

Exam Tip: The first phase of testicular descent is under MIS control; the second phase is under androgen (testosterone) control. The gubernaculum plays the key guiding role.

9.12 Müllerian (Paramesonephric) Duct Anomalies

Embryological Basis

• Origin: Müllerian (paramesonephric) ducts develop from coelomic epithelium of the urogenital ridge at 6 weeks gestation
• Female differentiation (absence of MIS): In the absence of SRY → no testes → no Müllerian Inhibiting Substance (MIS/AMH) → the Müllerian ducts persist and differentiate into:
• Fallopian tubes (cranial, unfused portion)
• Uterus (caudal, fused portion)
• Cervix
• Upper 2/3 of vagina
• Wolffian (mesonephric) ducts regress
• Fusion: The two Müllerian ducts fuse caudally at 8–12 weeks to form the uterovaginal canal
• Septum resorption: The intervening septum is resorbed from the caudal end upwards (completed by 9–12 weeks)
• Male differentiation (MIS present): Müllerian ducts regress under the influence of MIS secreted by fetal Sertoli cells

Classification Systems

System	Year	Description
American Fertility Society (AFS) — now ASRM	1988	7 Classes (I–VII): agenesis, unicornuate, didelphys, bicornuate, septate, arcuate, DES-related
ESHRE/ESGE	2013	Classification based on uterine anatomy, cervical/vaginal anomalies, and tubal status
VCUAM	2011	Vagina, Cervix, Uterus, Adnexa, and associated Malformations — systematic descriptive system

Exam Tip: The AFS 1988 classification is the most commonly tested in MRCOG exams.

---

Class I — Müllerian Agenesis (MRKH Syndrome)

Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome

• Incidence: ~1 in 4,500 female births
• Pathology: Absent uterus (or rudimentary non-canalised uterine remnants) and absent upper 2/3 of vagina
• Ovaries: Normal (therefore normal secondary sexual characteristics, normal hormonal profile)
• External genitalia: Normal
• Karyotype: 46,XX (normal female)
• Presentation: Primary amenorrhoea in an otherwise normal-appearing female with normal breast development and pubic hair
• Associated anomalies:
• Renal (40%): Unilateral renal agenesis, horseshoe kidney, ectopic kidney, pelvic kidney
• Skeletal (10–15%): Klippel-Feil syndrome (fusion of cervical vertebrae), scoliosis, limb defects
• Hearing loss: Sensorineural hearing loss
• Cardiac: Less common
• Management of vaginal agenesis:
• Non-surgical: Vaginal dilators — Frank method (progressive dilation) or Ingram method (dilation with bicycle seat stool)
• Surgical (neovagina creation):
  • McIndoe vaginoplasty: Split-thickness skin graft over a mould placed in a dissected vesicorectal space
  • Vecchietti procedure: Laparoscopic transperitoneal traction device that gradually pulls an olive upward to create neovagina
  • Davydov procedure: Laparoscopic peritoneal pull-through vaginoplasty
  • Soham procedure / Intestinal vaginoplasty: Use of a segment of sigmoid colon to create the neovagina
• Fertility: Absolute uterine infertility — surrogacy or uterine transplantation are the only options for genetic offspring

Exam Tip: MRKH = absent uterus + absent upper vagina + normal ovaries + 46,XX + primary amenorrhoea + normal secondary sexual characteristics. Always check renal tract when MRKH is suspected.

---

Class II — Unicornuate Uterus

• Pathology: Failure of one Müllerian duct to develop fully; the other duct forms a single uterine horn
• Incidence: ~5% of Müllerian anomalies
• Subtypes: | Type | Description | Clinical Significance | |------|-------------|---------------------| | (a) Communicating rudimentary horn | Rudimentary horn has a cavity that communicates with the main horn | Lower risk of haematometra | | (b) Non-communicating rudimentary horn (with endometrium) | Rudimentary horn has endometrium but no communication | High risk — haematometra → cyclic pain, dysmenorrhoea, endometriosis risk | | (c) No horn | No rudimentary horn present | — | | (d) No cavity | Rudimentary horn present but no endometrial cavity | — |
• 65% of unicornuate uteri have a rudimentary horn; of these, most are non-communicating
• Associated anomalies:
• Renal agenesis (40–50%): Ipsilateral to the absent horn — most common association
• Contralateral kidney may be normal or hypertrophied
• Obstetric outcomes:
• Miscarriage rate: 30–50%
• Preterm delivery: 15–30%
• Malpresentation: 30%
• IUGR: Increased risk
• Live birth rate: 40–60%
• Management:
• Consider laparoscopic excision of a non-communicating rudimentary horn (prevents haematometra, pain, and reduces endometriosis risk)
• High-risk obstetric monitoring in pregnancy

---

Class III — Uterus Didelphys

• Pathology: Complete failure of fusion of the two Müllerian ducts → two separate uterine horns, two separate cervices, frequently with a longitudinal vaginal septum
• Incidence: ~10% of Müllerian anomalies
• Key features:
• Two hemi-uteri, each with its own cervix
• Longitudinal vaginal septum (may be partial or complete)
• Can be symmetric or asymmetric (one horn may be smaller)
• Associated conditions:
• OHVIRA syndrome (Obstructed Hemivagina Ipsilateral Renal Anomaly):
  • Didelphys uterus + obstructed hemivagina + ipsilateral renal agenesis
  • Presents after menarche with progressively worsening dysmenorrhoea and pelvic mass (haematocolpos)
• Renal agenesis ipsilateral to the obstructed side
• Obstetric outcomes:
• Many women have successful pregnancies
• Miscarriage rate: 20–40%
• Preterm delivery: 20–40%
• Malpresentation: 30–40%
• Live birth rate: 50–70%
• Management:
• No treatment needed if asymptomatic
• Resection of the vaginal septum if obstructed (relieves haematocolpos, reduces pain)

Exam Tip: OHVIRA syndrome = didelphys + obstructed hemivagina + ipsilateral renal agenesis. Presents post-menarche with cyclic pain and a pelvic mass.

---

Class IV — Bicornuate Uterus

• Pathology: Incomplete fusion of the Müllerian ducts at the fundal level → two uterine horns with a single cervix and single vagina
• Incidence: ~25% of Müllerian anomalies
• Subtypes:
• Bicornuate unicollis: Single cervix (most common)
• Bicornuate bicollis: Two cervices (rare; difficult to differentiate from didelphys)
• Imaging features:
• Ultrasound / HSG: 'Heart-shaped' uterine cavity; intercornual angle > 105°
• MRI: External fundal cleft > 1 cm — this is the key feature that differentiates bicornuate from septate uterus
• Obstetric outcomes:
• Miscarriage rate: 25–40%
• Preterm delivery: 15–30%
• Malpresentation: 25–40%
• Live birth rate: 50–70%
• Surgical management (rarely indicated):
• Strassman metroplasty — unification of the two horns via a transverse fundal incision and reapproximation
• Indicated only for recurrent pregnancy loss after other causes excluded
• Rarely performed today; most cases managed expectantly with high-risk obstetric care

Exam Tip: Bicornuate vs septate differentiation: external fundal cleft >1cm = bicornuate; no external cleft = septate. MRI is the best modality to distinguish.

---

Class V — Septate Uterus

• Pathology: Complete or partial persistence of the uterovaginal septum after fusion of the Müllerian ducts
• Incidence: Most common Müllerian anomaly (~55%)
• Types:
• Complete septum: Extends from fundus to the cervical os (may extend into the vagina — septate cervix)
• Partial septum (subseptate): Only involves the upper portion of the cavity
• Key diagnostic feature: External fundal contour is normal (no cleft) — this is the critical difference from bicornuate uterus
• Septum composition: Fibrous and less vascular tissue → easy to resect, low bleeding risk during surgery
• Obstetric outcomes — WORST among Müllerian anomalies:
• Miscarriage rate (1st trimester): 20–65%
• Miscarriage rate (2nd trimester): Increased
• Preterm labour: 10–25%
• Malpresentation: 15–30%
• Live birth rate: 15–80% (dramatically improves after resection)
• Diagnosis:
• 3D transvaginal ultrasound — best first-line imaging
• MRI — excellent for assessing external fundal contour
• Hysteroscopy + laparoscopy — gold standard (hysteroscopy confirms septum, laparoscopy confirms normal external contour)
• Management:
• Hysteroscopic septum resection (septoplasty) — gold standard treatment
• Laparoscopy not needed if external contour confirmed normal by MRI/3D US
• Post-operative care:
  • Oestrogen therapy for 4–6 weeks to promote endometrial healing over the raw surfaces
  • Second-look hysteroscopy after 2–3 months to assess healing and rule out adhesions
• Outcome: Pregnancy outcomes improve significantly — live birth rates approach 80–90% after resection

Exam Tip: Septate uterus is the MOST common anomaly, associated with the HIGHEST pregnancy loss rate, and is the MOST treatable (hysteroscopic resection). Key differentiating feature from bicornuate = normal external fundal contour.

---

Class VI — Arcuate Uterus

• Pathology: Mild indentation of the endometrial cavity at the fundus; considered a normal variant by many authorities
• Incidence: Common; present in 3–5% of the general population
• Clinical significance: Minimal
• Slightly increased risk of second trimester loss (some studies)
• Obstetric outcomes:
• Miscarriage rate: 10–20% (close to normal population risk)
• Preterm delivery: 5–10%
• Malpresentation: ~8%
• Live birth rate: 70–85%
• Management:
• No surgical treatment indicated
• Reassurance

---

Class VII — DES-Related Anomalies

• Background: Diethylstilboestrol (DES) — a synthetic non-steroidal oestrogen — was prescribed between 1947–1971 for threatened miscarriage and high-risk pregnancy
• Pathology: In utero exposure to DES alters Müllerian duct development
• Uterine findings:
• T-shaped uterine cavity (most characteristic)
• Hypoplastic uterus
• Cervical collars, hoods, or cockscomb deformities
• Vaginal findings:
• Vaginal adenosis (presence of columnar epithelium in the vagina — precursor to clear cell adenocarcinoma)
• Clear cell adenocarcinoma of the vagina and cervix (rare but serious — incidence ~1 in 1,000 exposed females)
• Obstetric outcomes:
• Increased risk of ectopic pregnancy
• Increased miscarriage rate
• Preterm delivery
• Cervical insufficiency (due to cervical structural anomalies)
• Management:
• Cervical surveillance (regular Pap smears, colposcopy if needed)
• Pregnancy managed as high-risk with cervical length monitoring
• DES-exposed daughters should have lifelong gynaecological surveillance

Exam Tip: DES exposure → T-shaped uterus, vaginal adenosis, clear cell adenocarcinoma risk. In the MRCOG exam, this is the least common but most distinctive class.

---

Clinical Assessment of Müllerian Anomalies

Indications to investigate: - Recurrent first trimester miscarriage - Second trimester pregnancy loss - Dysmenorrhoea (especially if progressively worsening post-menarche) - Infertility - Obstetric complications (malpresentation, preterm labour) - Primary amenorrhoea

Investigations:

Modality	Role	Advantages	Limitations
3D Transvaginal Ultrasound (TVS)	First-line screening	Non-invasive, excellent visualisation of external & internal contour, widely available	Operator-dependent
Saline Infusion Sonography (SIS)	Cavity assessment	Delineates intrauterine contour well	Invasive (catheter), cannot assess external contour
Hysterosalpingography (HSG)	Tubal patency + cavity shape	Assesses tubal patency simultaneously	Radiation, no external contour, cannot differentiate septate vs bicornuate
MRI	Best for external contour assessment	Excellent soft tissue resolution, definitive for septate vs bicornuate	Cost, availability
Hysteroscopy + Laparoscopy	Gold standard for differential diagnosis	Direct visualisation of cavity (hysteroscopy) + external contour (laparoscopy); therapeutic (resection) possible in same sitting	Invasive, requires anaesthesia, operative risk

Key differentiation: Septate vs Bicornuate Uterus

Feature	Septate	Bicornuate
External fundal contour	No cleft (flat/convex)	Cleft > 1 cm
Intercornual angle	< 75°	> 105°
Cavity shape	Two cavities with normal outer contour	'Heart-shaped' on HSG
Best imaging	MRI or 3D US (external contour)	MRI or 3D US

---

Obstetric Outcomes in Uterine Anomalies

Anomaly	Miscarriage Rate	Preterm Delivery	Malpresentation	Live Birth Rate
Normal	10–15%	5–8%	5%	85–90%
Unicornuate	30–50%	15–30%	30%	40–60%
Didelphys	20–40%	20–40%	30–40%	50–70%
Bicornuate	25–40%	15–30%	25–40%	50–70%
Septate	20–65%	10–25%	15–30%	15–80% (better after resection)
Arcuate	10–20%	5–10%	8%	70–85%

Exam Tip: Septate uterus has the WORST pregnancy outcomes of all anomalies (highest miscarriage rate), but it is also the MOST TREATABLE — hysteroscopic resection dramatically improves outcomes.

---

Key MRCOG Exam Facts

1. Most common Müllerian anomaly: Septate uterus (~55%)
2. Worst obstetric outcome: Septate uterus — highest pregnancy loss rate
3. Most treatable: Septate uterus — simple hysteroscopic septum resection restores near-normal obstetric outcomes
4. MRKH syndrome: Absence of uterus + upper 2/3 vagina; normal ovaries; normal karyotype 46,XX; presents as primary amenorrhoea with normal secondary sexual characteristics
5. Bicornuate vs septate differentiation: External fundal contour on MRI or 3D ultrasound (cleft >1cm = bicornuate; no cleft = septate)
6. OHVIRA syndrome: Uterus didelphys + obstructed hemivagina + ipsilateral renal agenesis
7. DES exposure: T-shaped uterus; associated with vaginal adenosis and clear cell adenocarcinoma of vagina/cervix
8. Strassman metroplasty: Surgical unification of bicornuate uterus — rarely performed now, reserved for recurrent pregnancy loss
9. Müllerian & renal association: Both derived from intermediate mesoderm → always image the renal tract when a Müllerian anomaly is found

---

10. Development of Urinary System

10.1 Overview of Kidney Development

The urinary system develops through three successive, overlapping kidney systems: 1. Pronephros — rudimentary, non-functional 2. Mesonephros — briefly functional in early embryo 3. Metanephros — definitive, permanent kidney

All three arise from intermediate mesoderm.

10.2 Pronephros

Timing: Week 3–4.

Location: Cervical region.

Structure: - 7–10 pairs of pronephric tubules - Each tubule opens into the intraembryonic coelom via a nephrostome - The pronephric ducts form bilaterally - Completely regresses by week 4

Function: Non-functional in humans (vestigial). Exists as an evolutionary remnant.

10.3 Mesonephros

Timing: Weeks 4–10 (functionally active weeks 5–8).

Location: Thoracolumbar region (T10–L2).

Structure: - ~20–40 pairs of mesonephric tubules - Each tubule forms a glomerulus (filtering unit) surrounded by Bowman's capsule - Tubules drain into the mesonephric (Wolffian) duct - The mesonephros may produce urine that drains into the cloaca

Function: Probably functional as a temporary excretory organ; then regresses.

Fate: - In males: Some mesonephric tubules persist as the efferent ductules of the testis and the paradidymis - In females: Remnants become the epoophoron and paroophoron - The mesonephric duct becomes the vas deferens (male) or regresses (female)

10.4 Metanephros (Definitive Kidney)

Timing: Development begins at week 5; functional by week 9–10.

Location: Sacral region initially; then ascends.

Origin: Two distinct tissues that interact reciprocally:

Ureteric Bud

• Diverticulum from the distal mesonephric duct (near the cloaca)
• Grows dorsocranially and penetrates the metanephric blastema
• Induces the metanephric blastema to form nephrons
• Derivatives: Ureter, renal pelvis, major calyces, minor calyces, collecting ducts (all collecting system)

Metanephric Blastema (Metanephrogenic Mass)

• Caudal part of the intermediate mesoderm (nephrogenic cord)
• Forms around the ureteric bud
• Derivatives: Glomerulus (podocytes), proximal convoluted tubule, loop of Henle, distal convoluted tubule (all nephrons)

Reciprocal Induction: - Ureteric bud → induces metanephric blastema → nephron formation - Metanephric blastema → induces ureteric bud → branching morphogenesis (collecting system) - This mutual induction is essential — if either is absent, the kidney fails to develop

Nephron Formation

1. Ureteric bud branches repeatedly (up to 15–20 generations)
2. Each branch tip induces the metanephric blastema to form a nephron
3. The nephric vesicle → comma-shaped body → S-shaped body → capillary invasion → glomerulus
4. The proximal end forms Bowman's capsule; the distal end joins the collecting duct

Timeline of Nephrogenesis: - Begins week 7 - Continues until week 36 (no new nephrons after 36 weeks) - Each kidney has ~1 million nephrons at term

10.5 Ascent of the Kidneys

Timing: Weeks 6–9.

Process: - Initially, the metanephros lies in the sacral region (pelvis) - As the fetus grows, the kidneys ascend to their final position in the upper retroperitoneum (L1–L2) - Ascent is due to: differential growth of the body (the caudal end grows faster than the kidneys) + straightening of the embryo

Vascular Supply: - As the kidneys ascend, they receive blood from successively higher vessels - Initially supplied by: sacral → iliac → lumbar → renal arteries from the aorta - If the lower vessels persist, an accessory renal artery results (very common — 25–30% of individuals)

Rotation: - The kidneys also rotate medially (by ~90°) as they ascend - The renal hilum (where vessels enter) faces medially in the final position - The renal pelvis (anterior at onset) rotates medially

10.6 Cloaca, Urogenital Sinus & Bladder

Cloaca Formation (Week 4–6)

• The end of the hindgut is called the cloaca — an endoderm-lined chamber
• The cloaca is in contact with the surface ectoderm at the cloacal membrane (future external opening)
• The allantois (from hindgut) connects the cloaca to the umbilicus

Division of the Cloaca (Week 6–7)

The urorectal septum (a wedge of mesoderm between the allantois and hindgut) grows caudally towards the cloacal membrane:

Compartment	Derivatives
Anterior: Urogenital sinus	Urinary bladder, urethra, vestibular glands (female), prostate (male)
Posterior: Anorectal canal	Rectum, anal canal (upper ⅔)

The urorectal septum eventually meets the cloacal membrane, dividing it into: - Urogenital membrane (anterior) — breaks down to form the external urethral opening - Anal membrane (posterior) — breaks down to form the anus

Bladder Development

• The upper part of the urogenital sinus → urinary bladder
• The allantois connects the bladder apex to the umbilicus → becomes the urachus (later the median umbilical ligament)
• The bladder is initially continuous with the allantois
• The ureters (from ureteric buds) open into the bladder
• The mesonephric ducts (Wolffian) also open into the bladder initially, but as the bladder expands, they migrate caudally to open into the prostatic urethra (male) or regress (female)

Trigone of the Bladder: - Derived from the mesonephric ducts (mesodermal origin) — unlike the rest of the bladder (endodermal/urogenital sinus origin) - The trigone is the triangle between the two ureteric openings and the internal urethral orifice - Important surgical landmark

Urachus

• The intraembryonic part of the allantois becomes the urachus
• Normally obliterates → median umbilical ligament (postnatal fibrous cord)
• Clinical:
• Patent urachus: Urine leaks from umbilicus
• Urachal sinus: Partial patency near bladder or umbilicus
• Urachal cyst: Midline cyst between bladder and umbilicus; may become infected

10.7 Clinical Correlations of Urinary System

Anomaly	Description	Clinical Significance
Renal agenesis	Failure of ureteric bud formation or metanephric blastema induction	Unilateral (~1:1000) — usually asymptomatic; Bilateral (Potter syndrome ~1:4000) — fatal
Horseshoe kidney	Fusion of lower poles (most common renal fusion anomaly; 1:400)	Usually asymptomatic; higher risk of infection, stones, obstruction; commonly associated with Turner syndrome
Ectopic kidney	Failure of ascent (pelvic kidney)	Usually asymptomatic; risk of obstruction
Duplex kidney	Bifid ureteric bud → two ureters draining from one kidney	Can be asymptomatic or cause VUR/obstruction
Ureteropelvic junction (UPJ) obstruction	Narrowing at the junction of the renal pelvis and ureter	Most common cause of antenatal hydronephrosis
Posterior urethral valves	Congenital membrane in the male posterior urethra	Obstructive uropathy → bilateral hydronephrosis, renal dysplasia
Exstrophy of the bladder	Failure of the infraumbilical wall to fuse → bladder exposed	Complex surgical repair required

Potter Syndrome (Bilateral Renal Agenesis): - Features: Oligohydramnios (no fetal urine), Potter facies (low-set ears, flat nose, receding chin), pulmonary hypoplasia, limb deformities (positional) - Lethal — incompatible with extrauterine life due to pulmonary hypoplasia

Exam Tip: The ureteric bud comes from the mesonephric duct. The metanephric blastema forms the nephrons. Reciprocal induction is essential. The kidney ascends from S2 to L1–L2 during weeks 6–9.

---

11. Fetal Development Milestones

11.1 Carnegie Stages

The Carnegie staging system divides human embryonic development into 23 stages (from fertilisation to week 8), based on morphological features rather than age.

Stage	Timing (days)	Key Features
1	1	Fertilisation (zygote)
2	2–3	2- to 16-cell (cleavage)
3	4–5	Morula → blastocyst
4	6	Blastocyst implantation begins
5	7–12	Implantation, bilaminar disc
6	13–15	Primitive streak, gastrulation begins
7	16	Germ layers (trilaminar disc)
8	17–19	Notochord, neural plate
9	20	Neural folds, somites begin
10	22	Neural folds fuse, ~4 somites
11	24	Cranial neuropore closes, 13–20 somites
12	26	Caudal neuropore closes, 21–29 somites
13	28	Limb buds appear
14	32	Lens pits, optic vesicles
15	36	Hand plate, lens vesicles
16	40	Pigment in retina, foot plate
17	44	Finger rays, head growth
18	48	Ossification begins, ears
19	52	Trunk elongation
20	55	Upper limb longer
21	57	Fingers and toes
22	60	Eyelids, nipples
23	63 (9 weeks)	End of embryonic period; fetal period begins

11.2 Crown-Rump Length (CRL)

Definition: The longest measurement of the embryo/fetus from the crown (top of head) to the buttocks/rump, excluding the limbs.

Clinical Use: The most accurate method for dating pregnancy in the first trimester (up to ~12–13 weeks).

Estimates:

Gestation (weeks)	CRL (mm)
6	5
7	10
8	16
9	23
10	31
11	41
12	53
13	65
14	76

Formula: CRL (mm) = (Gestational age in days) + 42 (approximate, various formulas exist)

Important: CRL is most accurate for dating when measured between 7 and 12 weeks. After 12 weeks, other parameters are used.

11.3 Fetal Growth Parameters

Biparietal Diameter (BPD): - Measured across the fetal skull at the level of the thalami - Used from 12 weeks onward

Femur Length (FL): - Length of the femoral diaphysis - Correlates well with gestational age

Head Circumference (HC): - Measured around the fetal skull

Abdominal Circumference (AC): - Measured at the level of the liver and stomach - The best predictor of fetal weight

Fetal Weight Estimates (Approximate):

Gestation (weeks)	Weight (g)
12	14
16	100
20	300
24	600
28	1100
32	1800
36	2500
40	3400

11.4 Organ System Development Timings

Cardiovascular System

Event	Timing
Heart tube formation	Day 18–20
Heart begins to beat	Day 22
Folding — heart moves ventrally	Week 4
Cardiac septation begins	Week 4–5
Atrial septation complete	Week 6
Ventricular septation complete	Week 8
Foramen ovale and ductus arteriosus functional	Weeks 6+
Four-chamber heart	Week 8–9

Nervous System

Event	Timing
Neural plate forms	Day 17–19
Neural tube begins to close	Day 22
Cranial neuropore closes	Day 25
Caudal neuropore closes	Day 28
Brain vesicles (forebrain, midbrain, hindbrain)	Week 4–5
Cerebral cortex development	Weeks 7–16
Myelination begins	Week 20
Brain growth spurt	Weeks 20–40 (and postnatal)

Limbs

Event	Timing
Upper limb buds appear	Day 26 (stage 13)
Lower limb buds appear	Day 28
Hand paddle (flat plate)	Day 33
Foot paddle	Day 36
Finger rays	Day 41
Toe rays	Day 46
Limbs fully formed	Week 8

Gastrointestinal System

Event	Timing
Oropharyngeal membrane ruptures	Day 24
Oesophagus development	Week 4–5
Stomach rotation	Week 5–6
Midgut herniation into umbilical cord (physiological)	Week 6–10
Midgut returns to abdominal cavity	Week 10–11
Liver functions begin	Week 8
Pancreas development	Week 5–8
First fetal swallowing movements	Week 11–12
Meconium formation	Week 16+

Respiratory System

Event	Timing
Respiratory diverticulum (laryngotracheal bud) appears	Day 28
Trachea and oesophagus separate	Week 5
Bronchial buds appear	Week 5
Lung lobation	Week 6–7
Diaphragm separates thorax and abdomen	Week 7–10

Lung Development Stages

Stage	Timing	Description
Pseudoglandular	Weeks 5–16	Bronchial tree branching complete; all conducting airways formed; no gas exchange possible
Canalicular	Weeks 16–25	Bronchioles give rise to respiratory bronchioles; capillaries align with epithelium — gas exchange begins
Saccular	Weeks 25–36	Terminal sacs (alveolar saccules) form; thinning of epithelium; further capillary growth
Alveolar	Week 36 – 8 years	Mature alveoli develop; most alveoli form postnatally (~85% after birth)

Viability Threshold: ~24 weeks (with intensive care). The timing corresponds to the beginning of the saccular stage, when some gas exchange becomes possible.

Surfactant Production

Source: Type II pneumocytes (alveolar epithelial cells)

Timing: Begins at ~24 weeks; reaches mature levels by ~34–36 weeks.

Composition of Surfactant: - Phosphatidylcholine (lecithin) — ~70–80% (most abundant) - Dipalmitoylphosphatidylcholine (DPPC) is the major surface-active component - Phosphatidylglycerol (PG) — ~10% (appears later, sign of maturity) - Surfactant proteins: SP-A, SP-B, SP-C, SP-D (increase surface activity, immunity)

L/S Ratio (Lecithin/Sphingomyelin Ratio): - Used clinically to assess fetal lung maturity - <2.0: Immature lungs ↔ high risk of RDS - ≥2.0: Mature lungs - Phosphatidylglycerol (PG) present: Confirms maturity (appears at ~35–36 weeks) - Measured from amniotic fluid (via amniocentesis)

Surfactant Functions: 1. Reduces surface tension at the air-liquid interface → prevents alveolar collapse 2. Prevents respiratory distress syndrome (RDS) in the newborn 3. Stops exudation of fluid from pulmonary capillaries 4. Immune function (SP-A, SP-D are collectins — opsonise pathogens)

Factors Accelerating Surfactant Maturation: - Corticosteroids (betamethasone) — given antenatally to prevent RDS - Maternal stress/PPROM - Pregnancy-induced hypertension - IUGR

Factors Delaying Surfactant Maturation: - Prematurity - Maternal diabetes (infant of diabetic mother — higher risk of RDS) - Male fetus

Exam Tip: RDS (Hyaline Membrane Disease) is caused by surfactant deficiency in preterm infants. Antenatal corticosteroids (betamethasone 12 mg × 2 doses, 24 hours apart) accelerate surfactant production and reduce RDS risk.

11.7 Fetal Circulation

Unique Features of Fetal Circulation:

The fetal circulation differs fundamentally from the adult because the lungs are non-functional (gas exchange occurs at the placenta). Key structures that allow this adaptation:

Structure	Location	Function	Fate After Birth
Ductus venosus	Liver — shunts blood from umbilical vein to inferior vena cava	Bypasses the liver (carries oxygenated blood from placenta directly to the heart)	Constricts → ligamentum venosum
Foramen ovale	Interatrial septum	Shunts oxygenated blood from right atrium to left atrium (bypasses pulmonary circulation)	Closes → fossa ovalis
Ductus arteriosus	Between pulmonary trunk and descending aorta	Shunts blood from right ventricle (pulmonary trunk) to descending aorta (bypasses lungs)	Constricts → ligamentum arteriosum
Umbilical arteries	Internal iliac arteries → placenta	Carry deoxygenated blood to placenta	Obliterate → medial umbilical ligaments (not the median — that's the urachus)
Umbilical vein	Placenta → liver/ductus venosus	Carry oxygenated blood from placenta to fetus	Obliterates → ligamentum teres hepatis (round ligament of liver)

Pathway of Oxygenated Blood in the Fetus:

1. Oxygenated blood from the placenta → umbilical vein → enters the fetal body at the umbilicus
2. Umbilical vein → ductus venosus (bypasses liver sinusoids) → inferior vena cava (IVC)
3. A small portion of umbilical vein blood perfuses the liver (portal sinus)
4. IVC (mixed blood: oxygenated from ductus venosus + deoxygenated from lower body) → right atrium
5. In the right atrium, the foramen ovale directs the more oxygenated blood (from IVC) → left atrium → left ventricle → ascending aorta → brain and upper body
6. Deoxygenated blood from the superior vena cava (SVC) → right atrium → right ventricle → pulmonary trunk
7. Most of the right ventricular output bypasses the lungs via the ductus arteriosus → descending aorta → lower body + umbilical arteries → placenta

Key Principle: The fetal circulation ensures that the most oxygenated blood goes to the brain (via foramen ovale and left side of the heart), while less oxygenated blood goes to the lower body and back to the placenta.

Changes at Birth:

1. Clamping of the umbilical cord → cessation of umbilical-placental circulation → umbilical arteries constrict → ductus venosus closes
2. First breath → lung expansion → decreased pulmonary vascular resistance → increased pulmonary blood flow
3. Increased pulmonary venous return to the left atrium → increased left atrial pressure → foramen ovale closes (functionally within minutes, anatomically by ~1 year)
4. Increased oxygen tension → ductus arteriosus constricts (functional closure within 15 hours; anatomical closure as ligamentum arteriosum by 3 weeks)
5. The foramen ovale closes because left atrial pressure now exceeds right atrial pressure

Persistence of Fetal Circulation:

• Patent ductus arteriosus (PDA): Failure of ductus arteriosus to close → left-to-right shunt. Risk factors: prematurity, rubella infection. Treatment: indomethacin (inhibits prostaglandin synthesis → promotes closure) or surgical ligation.
• Patent foramen ovale (PFO): Found in ~25% of adults — usually asymptomatic but can cause paradoxical embolism.
• Persistent pulmonary hypertension of the newborn (PPHN): Failure of pulmonary vascular resistance to decrease at birth → right-to-left shunting across ductus arteriosus/foramen ovale → severe hypoxaemia.

Exam Tip: The difference between the fetal and postnatal circulation is a favourite exam topic. Remember: in the fetus, the most oxygenated blood goes to the brain; after birth, the lungs become the organ of oxygenation.

11.5 Other Organ Development Timings

System	Event	Timing
Eyes	Optic vesicles form; lens placode	Week 4
Ears	Otic placode → otic vesicle	Week 4
Face	Facial prominences fuse	Weeks 5–8
Teeth	Tooth buds	Week 6
Thyroid	Begins development	Week 4; completes descent by week 7
Parathyroids	From pharyngeal pouches	Week 5–6
Adrenal glands	Cortex from mesoderm; medulla from neural crest	Week 6–8; fetal adrenal is relatively huge
Kidneys	Metanephros functional	Week 9–10
Skin	Epidermis differentiates	Weeks 6–12
Genitalia	External genitalia identifiable	Week 12

11.6 Pharyngeal (Branchial) Arch Development

Definition: The pharyngeal arches are the embryological precursors of the face, neck, and upper aerodigestive tract.

Timing: Weeks 4–8.

Structure: Each arch has: - Core of mesoderm → muscles, arteries, skeletal components - Outer ectoderm → covers the external surface - Inner endoderm → lines the internal surface - Neural crest cells → contribute to skeletal and connective tissue elements - Each arch is separated by pharyngeal clefts (ectoderm) externally and pharyngeal pouches (endoderm) internally

The Six Pharyngeal Arches (Arch 5 regresses):

Arch	Nerve	Artery	Muscles Derived	Skeletal Derivatives
1st (Mandibular)	Trigeminal (V)	Maxillary artery (degenerates)	Muscles of mastication, mylohyoid, anterior belly of digastric, tensor tympani, tensor veli palatini	Maxilla, mandible, malleus, incus, sphenomandibular ligament
2nd (Hyoid)	Facial (VII)	Stapedial artery (degenerates)	Muscles of facial expression, stapedius, stylohyoid, posterior belly of digastric, auricular muscles	Stapes, styloid process, stylohyoid ligament, lesser horn of hyoid
3rd	Glossopharyngeal (IX)	Common carotid, internal carotid	Stylopharyngeus	Greater horn of hyoid
4th	Superior laryngeal (X)	Left side → aortic arch; Right side → right subclavian	Cricothyroid, levator veli palatini, pharyngeal constrictors	Thyroid cartilage, epiglottis
6th	Recurrent laryngeal (X)	Ductus arteriosus (left); pulmonary artery (right)	Intrinsic laryngeal muscles	Cricoid, arytenoid, corniculate cartilages

Pharyngeal Pouches (Endodermal Outpocketings):

Pouch	Derivative
1st	Auditory tube (Eustachian tube), middle ear cavity, mastoid antrum
2nd	Palatine tonsil (epithelial lining)
3rd	Inferior parathyroid glands + thymus
4th	Superior parathyroid glands + ultimobranchial body → parafollicular C-cells of thyroid

Pharyngeal Clefts:

Only the 1st cleft gives rise to a definitive structure: the external auditory meatus. The 2nd–4th clefts are normally obliterated as the 2nd arch grows over them (the cervical sinus).

Clinical Correlations: - Branchial cleft cyst: Remnant of the 2nd pharyngeal cleft → lateral neck cyst along the anterior border of sternocleidomastoid - Branchial fistula: Persistent opening from the tonsillar fossa to the skin - DiGeorge syndrome (22q11.2 deletion): Failure of 3rd and 4th pouch development → thymic aplasia (T-cell deficiency), parathyroid aplasia (hypocalcaemia), conotruncal cardiac defects - Pierre Robin sequence: Micrognathia (small mandible) → glossoptosis (posterior displacement of tongue) → cleft palate (failure of palatal shelf fusion due to tongue obstruction) - First arch syndrome: Treacher Collins syndrome (mandibulofacial dysostosis) — hypoplasia of the zygomatic bones, mandible, and ear anomalies

11.7 Heart Development (Detailed)

Timing: Days 18–50.

Key Stages:

1. Cardiogenic field formation (day 18): Mesodermal cells migrate to form a horseshoe-shaped region cranial to the oropharyngeal membrane
2. Heart tube formation (day 20): Two endocardial tubes fuse in the midline → single primitive heart tube
3. Cardiac looping (day 23–28): The heart tube loops to the right → the cardiac loop brings the chambers into their relative positions. The inflow (atrial) end moves posterior and superior; the outflow (ventricular) end moves anterior and inferior
4. Chamber formation (week 5–8): The four chambers form through septation

Cardiac Septation:

Septum	Structure	Timing	Clinical Defect
Septum primum	First atrial septum	Day 28–35	Ostium primum ASD (if fails to fuse with endocardial cushions)
Septum secundum	Second atrial septum	Day 33+	Ostium secundum ASD (most common ASD)
Endocardial cushions	AV canal septation	Day 35–42	AVSD/endocardial cushion defect (common in Down syndrome)
Muscular ventricular septum	Lower IVS	Day 37–45	Muscular VSD
Membranous ventricular septum	Upper IVS	Day 42–50	Membranous VSD (most common VSD)
Truncus arteriosus septum	Aorticopulmonary septum	Day 35–42	Truncus arteriosus, Tetralogy of Fallot, TGA (neural crest migration defects)

Viability Threshold: Around 24 weeks gestation (with modern neonatal intensive care). Survival at 22–23 weeks is possible but with significant morbidity.

11.6 Fetal Period Milestones (Weeks 9–40)

Weeks	Milestones
9–12	Face forms; external genitalia identifiable; ossification centres appear; urine production begins; swallowing movements
13–16	Fetal movements felt (quickening ~16–20 weeks); scalp hair pattern; meconium forms; sex identifiable on ultrasound
17–20	Fetal movements stronger; skin covered with vernix caseosa; lanugo appears; heart sounds audible with fetoscope
21–24	Eyelids open (week 24); fingernails present; lungs produce surfactant; viability threshold
25–28	Cerebral cortex matures; respiratory movements present; L/S ratio may reach 2.0; eyes open and blink reflex
29–32	Subcutaneous fat deposition; pupils react to light; rhythmic breathing movements; body less red, more smooth
33–36	Fingernails reach fingertips; pupillary light reflex present; skin pink and smooth; good head control by 36 wks
37–40	Term: defined as 37+0 to 42+0 weeks; lung maturation complete; thorax well-developed; testes descended in scrotum (term)

---

12. Congenital Abnormalities

12.1 Classification

The EMBRYOLOGIC classification of congenital anomalies:

Type	Definition	Cause	Example
Malformation	Intrinsically abnormal development of an organ/structure due to a genetic or environmental insult during the critical period of development	Genetic, teratogen, infection	Cleft lip, neural tube defect, congenital heart disease
Deformation	Extrinsically abnormal shape/position due to mechanical forces on a normally formed organ	Uterine constraint, oligohydramnios, fibroids	Clubfoot (talipes equinovarus), Potter facies, plagiocephaly
Disruption	Breakdown of previously normal tissue (secondary destruction)	Vascular accident, amniotic bands, infection	Amniotic band syndrome, limb reduction defects
Dysplasia	Abnormal cellular organisation or function within a tissue	Genetic defect in tissue development	Renal dysplasia, skeletal dysplasia (achondroplasia)

Additional Classification: - Sequence: A cascade of anomalies triggered by a single primary defect (e.g., Potter sequence — oligohydramnios from renal agenesis → facial compression, limb deformities, pulmonary hypoplasia) - Syndrome: A group of anomalies that occur together with a common aetiology (e.g., Down syndrome, Turner syndrome) - Association: Non-random grouping of anomalies without a common aetiology (e.g., VACTERL association) - Spectrum: Variable expression of related anomalies (e.g., PAS)

12.2 Aetiology of Congenital Anomalies

Cause	Contribution
Genetic (chromosomal + single gene)	~25–30%
Environmental (teratogens)	~10–15%
Multifactorial (genetic + environmental)	~50–60%
Unknown	~10–15%

12.3 Genetic Causes

Chromosomal Abnormalities: - Trisomies: 21 (Down), 18 (Edwards), 13 (Patau) — most common - Sex chromosome anomalies: Turner (45,X), Klinefelter (47,XXY) - Deletions: 22q11.2 (DiGeorge syndrome), 5p- (Cri-du-chat) - Structural rearrangements: Translocations, inversions

Single Gene Defects: - Autosomal dominant: Achondroplasia, Marfan, neurofibromatosis - Autosomal recessive: Cystic fibrosis, sickle cell disease - X-linked: Duchenne muscular dystrophy, haemophilia

12.4 Teratogens (Environmental Causes)

Definition: An agent that causes congenital anomalies by interfering with normal embryonic/fetal development.

Principles of Teratology (Wilson's 6 Principles): 1. Susceptibility depends on the genotype of the conceptus 2. Susceptibility varies with developmental stage at exposure 3. Teratogens act in specific mechanisms (cellular pathways) 4. The nature of the defect depends on the developmental stage at exposure 5. The dose and duration of exposure determine severity 6. Manifestations range from death to malformations to growth restriction to functional deficits

Critical Periods of Sensitivity

Period	Timing	Effect
Pre-differentiation (weeks 1–2)	Days 0–14	"All-or-nothing" — either embryo dies or recovers completely
Embryonic period (weeks 3–8)	Days 15–56	Maximum sensitivity — organogenesis; major malformations occur
Fetal period (weeks 9–40)	Weeks 9–40	Functional defects, growth restriction, minor anomalies

Exam Tip: The "all-or-nothing" period (weeks 1–2) means that teratogenic exposure at this stage either kills the embryo or is repaired completely — this is why women often don't know they're pregnant during this period and yet have normal babies.

Common Teratogens

Teratogen	Anomalies
Thalidomide	Limb reduction defects (phocomelia), ear malformations, cardiac defects
Alcohol (Fetal Alcohol Syndrome)	IUGR, microcephaly, facial dysmorphism (smooth philtrum, thin vermilion), developmental delay, intellectual disability
Valproate	Neural tube defects (especially spina bifida), facial dysmorphism, cardiac defects, neurodevelopmental delay
Warfarin	Nasal hypoplasia, stippled epiphyses (chondrodysplasia punctata), CNS defects
Lithium	Ebstein anomaly (tricuspid valve displacement)
Isotretinoin	CNS defects, microtia, cardiac defects, micrognathia
Methotrexate	Multiple anomalies, including neural tube defects, craniofacial, and limb defects
Tetracycline	Bone and teeth discolouration; no major malformations
ACE inhibitors	Oligohydramnios, renal dysplasia, IUGR (second/third trimester)
Carbamazepine	Neural tube defects (lower risk than valproate)
Diethylstilbestrol (DES)	Vaginal clear cell adenocarcinoma (in female offspring), T-shaped uterus, infertility

Maternal Infections (TORCH)

Infection	Effects on Fetus
Toxoplasmosis	Hydrocephalus, intracranial calcifications, chorioretinitis, IUGR
Rubella	Congenital rubella syndrome: Sensorineural deafness, congenital heart disease (PDA, pulmonary stenosis), cataracts, IUGR, microcephaly
Cytomegalovirus (CMV)	Microcephaly, periventricular calcifications, sensorineural hearing loss, chorioretinitis, IUGR
Herpes simplex (HSV)	Microcephaly, microphthalmia, skin vesicles; neonatal HSV is acquired at delivery (not typically teratogenic)
Syphilis	Hepatosplenomegaly, osteochondritis, rhinitis, rash, dental abnormalities (Hutchinson incisors, mulberry molars)
Parvovirus B19	Hydrops fetalis (due to aplastic anaemia), fetal death
Varicella zoster	Limb hypoplasia, skin scarring, microcephaly, cataracts (first trimester); neonatal varicella (around delivery)
Zika virus	Microcephaly, intracranial calcifications, ophthalmologic abnormalities, arthrogryposis

Mnemonic for TORCH: Toxoplasmosis, Other (syphilis, varicella, parvovirus, HIV, Zika), Rubella, CMV, Herpes

12.5 Common Abnormalities Relevant to O&G

Neural Tube Defects (covered in Section 5.5)

Prevalence: ~1 in 1,000 births (varies by population). Screening: Maternal serum alpha-fetoprotein (MS-AFP) at 16–18 weeks; detailed ultrasound. Diagnosis: Ultrasound (+ amniocentesis for AFP/acetylcholinesterase).

Cleft Lip and Palate

• Embryology: Failure of fusion of the medial nasal and maxillary prominences (cleft lip, ~week 5–7); failure of fusion of palatal shelves (cleft palate, ~weeks 6–9)
• Cleft lip = ± 1 in 1,000; Cleft palate = ± 1 in 2,000
• Association: Often syndromic (trisomy 13, trisomy 18, 22q11 deletion); Pierre Robin sequence (micrognathia → glossoptosis → cleft palate)
• Risk factors: Folate deficiency, smoking, alcohol, anticonvulsants, family history
• Feeding issues: Difficulty feeding, aspiration risk
• Management: Surgical repair (lip ~3–6 months, palate ~9–12 months)

Congenital Heart Defects

Defect	Description	Embryological Basis
Ventricular septal defect (VSD)	Defect in the interventricular septum	Most common CHD; failure of membranous/muscular septum closure
Atrial septal defect (ASD)	Defect in the interatrial septum	Secundum ASD (most common) — failure of ostium secundum closure; Primum ASD — failure of endocardial cushion fusion
Tetralogy of Fallot	VSD, overriding aorta, RV hypertrophy, pulmonary stenosis	Abnormal neural crest cell migration (aorticopulmonary septum)
Transposition of great arteries	Aorta from RV, pulmonary trunk from LV	Failure of spiraling of the truncus arteriosus septum
Patent ductus arteriosus (PDA)	Failure of ductus arteriosus closure	Normally closes within 72h of birth; associated with rubella, prematurity
Coarctation of the aorta	Narrowing of the aortic arch	Associated with Turner syndrome; often preductal
Ebstein anomaly	Displacement of tricuspid valve into RV	Associated with lithium exposure
Hypoplastic left heart	Underdeveloped left heart structures	Poor prognosis; requires staged surgical palliation (Norwood)

Diaphragmatic Hernia

• Embryology: Failure of the pleuroperitoneal membranes to close the pleuroperitoneal canals (~week 7–10)
• Most common type: Bochdalek hernia (posterolateral, 90%, left-sided 85%)
• Contents: Abdominal organs (stomach, intestines, spleen, liver) herniate into the thoracic cavity
• Consequence: Pulmonary hypoplasia (due to compression of developing lungs)
• Presentation: Respiratory distress at birth; scaphoid abdomen
• Prenatal diagnosis: Ultrasound — seen as bowel loops in the chest
• Management: Immediate intubation (avoid mask ventilation → bowel distension), NG tube, surgical repair after stabilisation; ECMO may be needed
• Prognosis: Depends on presence of associated anomalies and degree of pulmonary hypoplasia

Gastroschisis vs Omphalocele

Feature	Gastroschisis	Omphalocele
Defect location	Lateral to the umbilicus (usually right-sided)	Within the umbilical ring (midline)
Covering	No covering membrane (free-floating bowel)	Covered by amnion and peritoneum (sac)
Contents	Usually small intestine only	Bowel, stomach, liver (can include many organs)
Associated anomalies	Rare (usually isolated); bowel atresia can occur	Common — cardiac, neural tube, chromosomal (trisomy 13, 18, 21)
Umbilical cord insertion	Normal (adjacent to defect)	Into the sac itself
Incidence	~1 in 4,000	~1 in 5,000
Maternal age	Younger mothers	Any age
Prognosis	Good if no atresia; bowel function may be slow	Depends on associated anomalies; worse if large or syndromic

Other GI Congenital Anomalies

Anomaly	Description	Embryology
Oesophageal atresia ± tracheo-oesophageal fistula	Failure of oesophageal recanalisation + abnormal tracheo-oesophageal separation	TEF — abnormal division of foregut into trachea and oesophagus (~week 5)
Duodenal atresia	Obstruction of the duodenum	Failure of recanalisation (~week 8–10); associated with Down syndrome (30%)
Meconium ileus	Distal ileus obstruction by thick meconium	Associated with cystic fibrosis
Hirschsprung disease	Absence of ganglion cells in the distal colon	Failure of neural crest cell migration into hindgut
Imperforate anus	Absence of anal opening	Failure of the anal membrane to break down; often with VACTERL

Mnemonic for VACTERL Association: - Vertebral anomalies - Anal atresia / imperforate anus - Cardiac defects - Tracheo-Esophageal fistula - Renal anomalies - L**imb defects (radial aplasia)

Skeletal Congenital Anomalies

Anomaly	Description	Notes
Talipes equinovarus (clubfoot)	Medial deviation of the forefoot and inversion of the heel	May be positional (deformation) or structural; 1:1,000
Developmental dysplasia of the hip (DDH)	Abnormal hip joint development	Risk factors: breech, female, family history, oligohydramnios; screening with Ortolani and Barlow tests
Polydactyly	Extra digits	May be isolated or syndromic (e.g., trisomy 13)
Syndactyly	Fused digits	Failure of programmed cell death (apoptosis) between digits
Amniotic band syndrome	Constrictive bands causing amputations	Disruption — early rupture of amnion → fibrous bands entangle fetal parts

---

13. Twins & Multiple Pregnancy

13.1 Zygosity vs Chorionicity

Zygosity: Genotype — whether twins are monozygotic (identical) or dizygotic (fraternal). Determined at fertilisation.

Chorionicity: Placental anatomy — whether each twin has its own chorion/placenta or shares. Determined by timing of splitting (monozygotic only).

Chorionicity	Placentation	Intertwin Membrane	Always Dizygotic?
Dichorionic-Diamniotic (DCDA)	Two separate placentae (or fused), thick septum (4 layers: amnion-chorion-chorion-amnion)	Thick, can be separated	Dizygotic (always) OR monozygotic (if split day 0–3)
Monochorionic-Diamniotic (MCDA)	One shared placenta, thin septum (2 layers: amnion-amnion)	Thin	Only monozygotic
Monochorionic-Monoamniotic (MCMA)	One shared placenta, no septum	None	Only monozygotic
Conjoined	One shared placenta	None	Only monozygotic

13.2 Dizygotic (Dizygotic) Twins

Definition: Two separate ova fertilised by two separate spermatozoa.

Frequency: ~70% of all twins (varies by population).

Timing: Two independent fertilisations in the same menstrual cycle.

Placentation: Always DCDA (two separate chorions); placentae may be separate or fused (if implantation sites are close).

Risk Factors (for dizygotic twinning): - Maternal age (peak 35–39) - Parity (increasing parity → increasing risk) - Genetic/familial (maternal line — hyperovulation tendency) - Assisted reproductive technology (ART) — especially ovulation induction, IVF with multiple embryo transfer - Ethnicity (highest in Nigeria, lowest in Japan) - Higher BMI - Nutrition (dairy products, folic acid)

Mechanism: Double ovulation (or superovulation with ART).

13.3 Monozygotic (Identical) Twins

Definition: One fertilised ovum splits into two genetically identical embryos.

Frequency: ~30% of twins (~1 in 250 pregnancies); random occurrence (no familial inheritance).

Timing: The timing of the split determines the chorionicity:

Timing of Split	Day	Chorionicity	Incidence (of MZ twins)
Very early	Days 0–3 (up to morula stage)	Dichorionic-Diamniotic (DCDA)	~25–30%
Early	Days 4–8 (blastocyst before implantation)	Monochorionic-Diamniotic (MCDA)	~70–75%
Late	Days 8–12 (after implantation, before amniogenesis)	Monochorionic-Monoamniotic (MCMA)	~1–2%
Very late	Day 13+ (after the embryonic disc has formed)	Conjoined twins	Very rare (<1%)

Mnemonic: "3-4-8-13" — Split by day 3 = DCDA; by day 4–8 = MCDA; by day 8–12 = MCMA; day 13+ = conjoined.

Exam Tip: Monochorionic = always monozygotic. Dichorionic can be either monozygotic or dizygotic. The only way to determine zygosity is by DNA testing (or opposite-sex twins = dizygotic).

13.4 Timing of Chorionicity Determination

First Trimester Ultrasound (Gold Standard):

Sign	DCDA	MCDA	MCMA
Lambda (twin peak) sign	Present (triangular projection of placental tissue into the intertwin membrane)	Absent	N/A (no membrane)
T-sign	Absent	Present (membrane inserts directly into the placenta at a right angle)	N/A
Membrane thickness	Thick (>2 mm, 4 layers)	Thin (≤2 mm, 2 layers)	No membrane
Placental mass	Two separate or fused	Single	Single
Separation of membranes	Can be peeled apart (4 layers)	Cannot be separated (2 layers fused)	N/A

Why this matters: - Monochorionic twins have significantly higher morbidity and mortality than dichorionic twins - They share a single placenta → risk of: - Vascular anastomoses → Twin-to-twin transfusion syndrome (TTTS) - Selective IUGR (sIUGR) - Twin anaemia-polycythaemia sequence (TAPS) - Acardiac twin (TRAP sequence)

13.5 Placental Anastomoses in Monochorionic Twins

Types of Vascular Connections:

Type	Direction	Identification
Artery-to-artery (AA)	Bidirectional	Direct connection between two arteries; seen as a visible link on the placental surface
Vein-to-vein (VV)	Bidirectional	Direct connection between two veins
Artery-to-vein (AV)	Unidirectional (deep, via a shared cotyledon)	Blood flows from artery of one twin → shared cotyledon → vein of the other twin

Clinical Significance: - Almost all monochorionic placentae have vascular anastomoses (95+%) - AV anastomoses are the most clinically significant — they create unbalanced flow - AA anastomoses are usually protective (bidirectional flow balances pressure) - TTTS occurs when there is a net unbalanced AV anastomosis with insufficient compensatory AA anastomoses

13.6 Twin-to-Twin Transfusion Syndrome (TTTS)

Definition: A complication of monochorionic twinning where there is chronic, unbalanced arteriovenous anastomoses → one twin (donor) pumps blood to the other (recipient).

Incidence: ~10–15% of monochorionic twins.

Diagnosis (Quintero Staging):

Stage	Donor Twin	Recipient Twin	Ultrasound Features
Stage I	Oligohydramnios (DVP <2 cm)	Polyhydramnios (DVP >8 cm)	Bladders visible in both
Stage II	Oligohydramnios	Polyhydramnios	Donor bladder not visible
Stage III	Oligohydramnios	Polyhydramnios	Abnormal Doppler (absent/reversed end-diastolic flow in umbilical artery, reversed flow in ductus venosus, or pulsatile umbilical vein)
Stage IV	Oligohydramnios	Polyhydramnios	Hydrops in either or both twins
Stage V	Intrauterine fetal death (IUFD) of one or both twins

Criteria for TTTS: 1. Monochorionic pregnancy (confirmed) 2. Oligohydramnios in one sac (DVP <2 cm) 3. Polyhydramnios in the other sac (DVP >8 cm, or >10 cm after 20 weeks) 4. Discordant bladder sizes (absent bladder in donor, large bladder in recipient)

Pathophysiology: - Chronic transfusion: donor twin → hypovolaemia, oliguria, oligohydramnios, growth restriction - Recipient twin → hypervolaemia, polyuria, polyhydramnios, cardiac strain, hypertension, hydrops

Management: - Stage I: Expectant management or laser - Stages II–IV: Fetoscopic laser photocoagulation of anastomoses (selective laser ablation) — the standard of care - Alternative: Amniodrainage (symptomatic relief), septostomy (creating hole in membrane) - Stage V: Delivery or palliation

Outcomes: Laser therapy → ~70–80% survival of at least one twin; ~50–60% survival of both twins.

13.7 Twin Anaemia-Polycythaemia Sequence (TAPS)

Definition: A chronic form of TTTS without typical oligo/polyhydramnios sequence. Thought to result from small, unidirectional AV anastomoses that cause slow transfusion over time.

Types: - Spontaneous TAPS: ~3–5% of monochorionic twins - Post-laser TAPS: ~2–16% after laser treatment for TTTS

Diagnosis (Prenatal): - Discordant Middle Cerebral Artery Peak Systolic Velocity (MCA-PSV) : - Donor (anaemic) twin: MCA-PSV >1.5 MoM - Recipient (polycythaemic) twin: MCA-PSV <1.0 MoM - Discordant placental colour (donor side pale, recipient side congested)

Postnatal Diagnosis: - Discordant haemoglobin levels (donor Hb < recipient Hb by >8 g/dL) - Discordant reticulocyte count (donor: reticulocytosis)

Management: - Similar to TTTS — fetoscopic laser - Intrauterine transfusion (donor) + partial exchange transfusion (recipient) — alternative

13.8 Selective IUGR (sIUGR) in Monochorionic Twins

Definition: Discordant growth in monochorionic twins (one twin <10th centile) due to unequal placental sharing.

Classification (based on umbilical artery Doppler):

Type	Doppler of the smaller twin	Description
Type I	Positive end-diastolic flow (EDF)	Good prognosis; usually expectant management
Type II	Absent/reversed EDF persistently	Worse prognosis; high risk of deterioration
Type III	Intermittent absent/reversed EDF	Variable prognosis; risk of sudden death of the small twin

Management: - Close surveillance (Doppler, growth scans every 2 weeks) - If deterioration: consider laser ablation, cord occlusion (if one twin is dying), or delivery

13.9 Acardiac Twin / TRAP Sequence

TRAP = Twin Reversed Arterial Perfusion Sequence

Definition: A rare complication of monochorionic twinning (~1% of MZ twins) where one twin (the "pump" twin) perfuses the other (the "acardiac" twin) via a large AA anastomosis.

Pathophysiology: 1. AA anastomosis in the placenta → blood flows from the pump twin's umbilical artery → acardiac twin's umbilical artery (retrograde flow) 2. The acardiac twin is perfused with deoxygenated blood → severe maldevelopment 3. The acardiac twin lacks a functional heart (hence "acardiac") 4. Upper body development is poorest (no head, no arms, just a torso + legs — "amorphous") 5. The pump twin perfuses the acardiac mass → high-output cardiac failure risk

Risks to Pump Twin: - Polyhydramnios - Preterm labour - Hydrops fetalis (high-output cardiac failure) - Intrauterine death (~50% if untreated)

Management: - Radiofrequency ablation (RFA) of the acardiac twin's umbilical cord vessels (interrupts flow) - Fetoscopic laser or cord coagulation - Survival of the pump twin: ~80% with intervention

Diagnosis: - Monochorionic twins with one structurally abnormal twin (no heart, amorphous) - Reversed flow in the acardiac twin's umbilical artery (toward the twin) - Doppler shows continuous flow from pump → acardiac twin

13.10 Complications Summary by Chorionicity

Complication	DCDA	MCDA	MCMA
TTTS	Not possible	~10–15%	Up to 30%
TAPS	Not possible	~3–5%	Rare
sIUGR	Uncommon	~15–25%	~15–25%
TRAP	Not possible	Rare (~1%)	Rare
Cord entanglement	Not possible	Not possible	~30–50%
Cord prolapse	Equal risk	Equal risk	Higher risk
Congenital anomalies	Same as singleton	Higher (especially cardiac)	Higher
Preterm delivery (<37 wks)	~40–50%	~60%	~90%+
Fetal death	~2–5%	~10–15%	~20–30%
Neurological disability	~2%	~5–10%	~10–20%

Key Takeaway: Monochorionic (especially MCMA) pregnancies are HIGH RISK and require intensive fetal surveillance (ultrasound every 2 weeks from 16 weeks onward).

13.11 Management of Twin Pregnancies

First Trimester — Establishing Chorionicity: - Ultrasound at 10–14 weeks (best window for chorionicity determination) - Lambda sign = DCDA; T-sign = MCDA; absent membrane = MCMA - Identify each twin's position, size (CRL), and nuchal translucency

Second Trimester Surveillance: - DCDA twins: Growth scans every 4 weeks from ~20 weeks - MCDA twins: Growth scans every 2–3 weeks from 16–18 weeks - Monitor for TTTS (fluid volumes, bladder sizes) - Doppler studies (MCA-PSV for TAPS screening) - MCMA twins: Very high risk (cord entanglement); consider early admission and planned caesarean at 32–34 weeks

Third Trimester — Timing of Delivery: - DCDA: Planned delivery at 37–38 weeks (if uncomplicated) - MCDA: Planned delivery at 36–37 weeks (lower threshold due to increased stillbirth risk) - MCMA: Planned caesarean at 32–34 weeks (after corticosteroids for lung maturation) - TTTS post-laser: Delivery planned at ~34–36 weeks depending on outcome - sIUGR: Timing depends on Doppler status and growth trajectory

Mode of Delivery: - Both cephalic: Can aim for vaginal delivery (but with facilities for emergency CS) - Non-cephalic presenting twin: Usually planned caesarean - MCMA: Always caesarean (risk of cord entanglement during labour) - MCDA with TTTS/sIUGR: Usually caesarean (fetal reasons) - Monochorionic monoamniotic: Always caesarean

13.12 Complications of Twin Pregnancy

Complication	Explanation
Preterm labour/stillbirth	Most common complication — uterine distension, increased stretch
Pre-eclampsia	2–3× increased risk vs singleton
Gestational diabetes	Increased risk
Anaemia	Increased demands
Postpartum haemorrhage	Uterine overdistension, atony, large placental site
Malpresentation	At least one twin is non-cephalic in ~40%
Umbilical cord prolapse	Especially after rupture of membranes of second twin
Placental abruption	Increased risk (especially after delivery of first twin)
Locked twins	Rare but dangerous — both heads engage simultaneously
Vanishing twin	Early loss of one twin → absorbed; may cause bleeding; usually no harm to surviving twin
Fetal death in utero of one twin	DCDA — usually no effect on other twin; MCDA — risk of acute transfusion to dead twin → DIC, neurological injury in survivor

13.13 Zygosity Testing

Methods: - DNA microsatellite analysis: The gold standard — compare multiple polymorphic markers - Same sex + monochorionic = monozygotic (by definition) - Opposite sex = dizygotic (by definition) - Same sex + dichorionic: Only DNA testing can determine zygosity

Why determine zygosity? - Research purposes - Organ transplant compatibility - Understanding genetic vs environmental contributions - Recurrence risk counselling (dizygotic twinning has a familial component; monozygotic does not)

13.14 Higher-Order Multiples (Triplets+)

Incidence: ~1 in 8,000 (spontaneous), much higher with ART (up to 1 in 50 with ovulation induction)

Chorionicity in Triplets: - Can be trichorionic, dichorionic (with one monochorionic pair), or monochorionic - Monochorionic triplets are extremely rare but carry very high risk

Management: - MFPR (Multifetal pregnancy reduction): Reducing triplets to twins to improve outcomes for surviving fetuses - Fetoscopic laser: Used if TTTS develops within a monochorionic pair - Timing of delivery: Usually 32–34 weeks for trichorionic triplets; earlier for monochorionic

Risks: - Preterm birth (almost universal) - Discordant growth (common) - Congenital anomalies (higher in spontaneously conceived triplets) - Pre-eclampsia (5× risk vs singleton)

---

Quick-Reference Tables & Mnemonics

Germ Layer Derivatives Summary

Layer	Surface Covering	Internal Organs	Skeletal/Connective
Ectoderm	Epidermis, cornea, lens, inner ear, nasal epithelium, enamel	Brain, spinal cord, pituitary, adrenal medulla	Craniofacial skeleton (neural crest)
Mesoderm	Dermis, serous membranes	Heart, kidneys, gonads, spleen, adrenal cortex	Skeleton (except craniofacial), muscles, connective tissue
Endoderm	GI lining, respiratory lining	Liver, pancreas, thyroid, parathyroid, thymus	—

Key Embryological Timings

Event	Timing
Fertilisation	Day 0 (ovulation + 24h)
Implantation	Days 6–10
Primitive streak appears	Day 15
Notochord formed	Day 16–20
Heart begins to beat	Day 22
Cranial neuropore closes	Day 25
Limb buds appear	Day 26–28
Caudal neuropore closes	Day 28
Somites appear	Day 20+ (3 pairs/day)
Chorionic villi (tertiary)	End of week 3
Palatal fusion complete	Week 9
Sex distinguishable	Week 12
Viability threshold	~24 weeks
Nephrogenesis complete	Week 36
Surfactant mature	~34–36 weeks
Term	37–42 weeks

Hormone Quick Reference

Hormone	Source	Key Role in Embryology
hCG	Syncytiotrophoblast	Maintains corpus luteum; pregnancy test
hPL	Syncytiotrophoblast	Metabolic adaptation; insulin antagonism
Progesterone	Corpus luteum → placenta	Maintains endometrium; suppresses uterine contractility
Oestrogen	Placenta (from fetal DHEA-S)	Uterine growth; breast development
MIS/AMH	Sertoli cells (fetal testis)	Müllerian duct regression
Testosterone	Leydig cells (fetal testis)	Wolffian duct differentiation; male external genitalia
DHT	Target tissues (via 5α-reductase)	Male external genitalia development
Surfactant	Type II pneumocytes	Lung compliance; prevents RDS

Mnemonic Summary

Germ Layer Derivatives — "Inside Out"

Endoderm = Inside (Gut, Liver, Pancreas, Lungs) Mesoderm = Middle (Muscle, Bone, Kidney, Heart, Blood) Ectoderm = Extreme (Epidermis, Eyes, Ears, Nerves, Brain)

Neural Crest Derivatives — "Mr POSH"

Peripheral nerves (ganglia) Odontoblasts (dentin) Schwann cells Hormones (adrenal medulla)

Or "SCAM" : Schwann cells, Chromaffin cells, Autonomic ganglia, Melanocytes

NTD Prevention — Folate Mnemonic

Folic acid Once Daily Around Conception — FODAC (400 μg → 5 mg for high risk)

TTTS Quintero Stages — "B³D"

Bladder absent = Stage II Doppler abnormal = Stage III Dropsy = Stage IV Death = Stage V

Müllerian Anomalies — "Some Birth Defects Create Uterine Problems"

Septate Bicornuate Didelphys Complete septate Unicornuate Hypoplastic/AR"k"H (MRKH)

Potter Sequence — "POTTER"

Pulmonary hypoplasia Oligohydramnios Twisted face (Potter facies) Talipes (clubfeet) Extremity deformities (positional) Renal agenesis

Pharyngeal Arch Nerve Supply — "5, 7, 9, 10, 10"

1st arch = CN V (Trigeminal) 2nd arch = CN VII (Facial) 3rd arch = CN IX (Glossopharyngeal) 4th arch = CN X (Superior laryngeal branch) 6th arch = CN X (Recurrent laryngeal branch)

Palatal Closure Timing — "9 Weeks"

The palatal shelves fuse at 9 weeks. This is critical for understanding why cleft palate occurs: any insult before 9 weeks can prevent fusion.

Embryonic Period Vulnerability — "3 to 8"

The critical period of sensitivity to teratogens is weeks 3 to 8 (the period of organogenesis). Before week 3 is the "all-or-nothing" period; after week 8 is the fetal period (functional defects, growth restriction, but no major malformations).

Fetal Circulation Shunts — "Ducts and Holes"

Ductus Venosus = Vein → bypasses liver Foramen Ovale = Opening between atria Ductus Arteriosus = Artery → bypasses lungs Mnemonic: "Ductus Venosus Vein, Ductus Arteriosus Artery, Foramen Ovale Opening"

Umbilical Cord Vessels — "2A 1V"

2 Arteries carry deoxygenated blood Away from the fetus 1 Vein carries oxygenated blood Vein-toward the fetus (like returning home) Mnemonic: "2 A's go to the placenta (Away), 1 V returns (Victory for oxygen)"

Teratogens by System Affected:

Valproate → Vertebral (spina bifida) Alcohol → All systems (especially CNS + face) Lithium → Low tricuspid (Ebstein) Warfarin → Wonky nose (nasal hypoplasia) Thalidomide → THumbs and Arms (limb reduction) DES → Daughters' Exposed → Structural uterine anomalies + adenocarcinoma Isotretinoin → Is for CNS, Is for face (microtia, micrognathia) Rubella → Rings, Regurgitation, Retardation (PDA, cataracts, deafness)

Chorionicity Determination:

Lambda = Lots of layers (4) = Lots of chorion = Dichorionic T-sign = Thin (2 layers) = Two amnions only = Monochorionic Mnemonic: "Lambda = Lots, T-sign = Thin"

---

Final Exam Tips for MRCOG Part 1

1. Understand mechanisms, not just facts — MRCOG explores "why" not just "what." For example, knowing that monochorionic twins occur from splitting after day 4 is not enough — understand why this timing matters for chorionicity.
2. Chorionicity is the key to twin pregnancy — know the timing of splitting and its implications. Lambda sign = DCDA; T-sign = MCDA. Always establish chorionicity in the first trimester.
3. Know the critical periods — weeks 3–8 are the most sensitive for major malformations. The "all-or-nothing" period (weeks 1–2) means the embryo either dies or recovers fully.
4. Gametogenesis arrest points — primary oocyte at prophase I (dictyotene); secondary oocyte at metaphase II. This is frequently tested.
5. Surfactant biology — L/S ratio, PG, type II pneumocytes, betamethasone acceleration. Know the lung stages: pseudoglandular (5–16w), canalicular (16–25w), saccular (25–36w), alveolar (36w+).
6. Neural tube defects — closure timing (cranial neuropore day 25, caudal day 28), folate prevention, types of spina bifida. Folate reduces risk by 70%.
7. Germ layer derivatives — a classic MRCOG question; be systematic about ectoderm, mesoderm, endoderm. Know neural crest derivatives specifically.
8. Placental circulation — deoxygenated blood in 2 arteries → uterus → placenta → oxygenated blood in 1 vein → fetal heart. The placental membrane thins dramatically as pregnancy advances.
9. Sex determination — SRY drives male development; absence = female (default pathway). Wolffian ducts need testosterone; Müllerian ducts need MIS to regress.
10. Amniotic fluid — "Pee or Swallow" — fetal urine is the primary source after 16 weeks; fetal swallowing is the primary removal mechanism. Peak volume at 34–36 weeks (~1,000 mL).
11. Teratogen timing — the "all-or-nothing" period (weeks 1–2) is forgiving; the embryonic period (weeks 3–8) is the critical window for major anomalies; the fetal period (weeks 9–40) is for functional defects.
12. Placental endocrinology — the fetal-placental unit: the placenta needs fetal DHEA-S to make oestrogen. The luteal-placental shift occurs at 8–10 weeks.
13. Fetal circulation — three shunts: ductus venosus (liver bypass), foramen ovale (atrial bypass), ductus arteriosus (pulmonary bypass). The most oxygenated blood goes to the brain.
14. Pharyngeal arches — know the derivatives (mandible, hyoid, thyroid cartilage) and the nerve supply (CN V, VII, IX, X). DiGeorge syndrome affects 3rd and 4th pouches.
15. Müllerian anomalies — associated with renal anomalies (both from intermediate mesoderm). MRKH = absent uterus/upper vagina, normal ovaries, 46,XX.

Common MRCOG Part 1 Embryology Mistakes to Avoid: - Confusing the primary oocyte (arrested at prophase I) with the secondary oocyte (arrested at metaphase II) - Thinking the bilaminar disc differentiates into three layers without gastrulation - Believing dizygotic twins can be anything other than DCDA - Confusing the allantois with the yolk sac (allantois = hindgut diverticulum → urachus; yolk sac = vitelline duct → Meckel's) - Thinking the zona pellucida persists after implantation (it's shed during hatching) - Confusing the second polar body timing (formed at fertilization, after sperm entry) - Mixing up the ductus venosus (vein), ductus arteriosus (artery), and urachus (bladder-umbilicus)

This comprehensive guide covers the MRCOG Part 1 embryology syllabus. It requires active recall and practice questions for consolidation. Good luck with your preparation.

○ Mark as completed